Home Physical Sciences A review on 3D printing in tissue engineering applications
Article Publicly Available

A review on 3D printing in tissue engineering applications

  • Mohan Prasath Mani , Madeeha Sadia , Saravana Kumar Jaganathan EMAIL logo , Ahmad Zahran Khudzari , Eko Supriyanto , Syafiqah Saidin , Seeram Ramakrishna , Ahmad Fauzi Ismail and Ahmad Athif Mohd Faudzi
Published/Copyright: January 10, 2022
Become an author with De Gruyter Brill

Abstract

In tissue engineering, 3D printing is an important tool that uses biocompatible materials, cells, and supporting components to fabricate complex 3D printed constructs. This review focuses on the cytocompatibility characteristics of 3D printed constructs, made from different synthetic and natural materials. From the overview of this article, inkjet and extrusion-based 3D printing are widely used methods for fabricating 3D printed scaffolds for tissue engineering. This review highlights that scaffold prepared by both inkjet and extrusion-based 3D printing techniques showed significant impact on cell adherence, proliferation, and differentiation as evidenced by in vitro and in vivo studies. 3D printed constructs with growth factors (FGF-2, TGF-β1, or FGF-2/TGF-β1) enhance extracellular matrix (ECM), collagen I content, and high glycosaminoglycan (GAG) content for cell growth and bone formation. Similarly, the utilization of 3D printing in other tissue engineering applications cannot be belittled. In conclusion, it would be interesting to combine different 3D printing techniques to fabricate future 3D printed constructs for several tissue engineering applications.

1 Introduction

In recent years, many researchers have aimed to increase the functionality of tissue-engineered constructs which has shifted towards developing cell-seeded implants that support native tissues concerning anatomical geometry, cell placement, and the microenvironment of the cells. The development of engineered structures will promote sufficient transport of nutrients suitable for integration with systemic circulation, adequate mechanical support, and incorporation of multiple cell types for tissue regeneration [1, 2]. Three-dimensional printing (3DP) procedure was utilized to manufacture scaffolds with a novel small-scale and large-scale design [3]. It is a fabrication technique that can produce 3D objects geometries and internal architectures in a regulated manner such as pore size [4, 5]. This fabrication technique has been widely used to design scaffolds or cell-laden constructs in tissue engineering and regenerative medicine with enhanced control properties in terms of material and cells placement in 3D technology [4]. 3D bioprinted design process of human tissue structures is all more complex than the formation of natural extracellular matrix [6] and simple cells layer [7]. However, some researches have shown a distinct impact on cell properties such as cell migration, differentiation [8], and proliferation [7] in comparison with 2D constructs [6]. It was suggested that 3D bioprinted constructs were required to trigger indigenous extracellular matrix [7]. According to the research, hydrogels [9, 10] and porous structures are the two biomaterials types that are extensively examined for 3D printed constructs [7]. Moreover, 3DP of physiologically appropriate tissue reconstructions has already been shown to be an essential tool for surgery and prothesis [11]. 3DP technologies allow the customized creation of complicated multi-material implants for patient-specific geometries for medical prostheses in the field of tissue engineering [12]. One of the biggest challenges on the subject is the creation of materials (i.e. ink) [13]. When expanding into mechanically strong 3D imprinted structures, printable materials need to have rheological characteristics to allow extrusion and solidification. The materials must be biocompatible and completely degradable for medical implants while supporting the regeneration of tissue and proper functionality over the lifespan of the device. To facilitate the inclusion of biological components (for example, cells, biologic cytokines, and growth hormones) into printed structures, pre- or post-processing of the material must also retain biocompatibility [14]. Research studies reported that fabricated 3D printed constructs have complex geometry but lack cell distribution. It was found to be technically difficult to seed cell types onto a solid porous structure that includes inefficient static cell seeding of scaffold which causes heterogeneous cell distribution. Therefore, organ printing is a new approach in cell-based tissue engineering which develops a cell laden hydrogel scaffold with customized external shape and reproductive internal morphology using rapid prototyping (RP). On another side, 3D printing technique will help to enable fabrication of vascular beds and will enhance cell viability and survival rates after implantation [1, 2]. Furthermore, RP strategies have been used by tissue designers to deliver three-dimensional (3D) permeable frameworks. RP innovations permit the plan and manufacture of complex framework geometries with a completely interconnected pore arranges [3]. In another research study it was notified that, musculoskeletal tissue, bone and ligament are under broad examination in tissue engineering research. Various biodegradable and bioresorbable materials, used as framework structures, have been tentatively as well as clinically considered. Preferably, a scaffold ought to have the accompanying qualities: (i) three-dimensional and profoundly permeable with an interconnected pore arrange for cell development and stream transport of supplements and metabolic waste; (ii) biocompatible and bioresorbable with a controllable debasement and resorption rate to coordinate cell/tissue development in vitro or potentially in vivo; (iii) reasonable surface science for cell connection, expansion, and differentiation; and (iv) mechanical properties to coordinate those of the tissues at the site of implantation [1516]. Figure 1 represents the potential tissue-engineered items which include cartilage, bone, heart valves, nerves, muscle, bladder, liver, etc. However, tissue engineering strategies for most parts required the utilization of a permeable framework, which fills in as a 3D layout for introductory cell connection and ensuing tissue arrangement both for in vitro and in vivo methods. In addition, the scaffold gives vital help to cells to attach, proliferate, and keep up their separated capacity. This is an engineering approach that characterizes a definitive state of the new become delicate or hard tissue [17, 18]. Hence, 3D bioprinting adds a noteworthy advancement in the restorative field of tissue engineering by taking into consideration research to be done on inventive materials called biomaterials. This review has highlighted an overview of three important 3D printing approaches (1) inkjet bioprinting, (2) extrusion-based bioprinting, and (3) laser-assisted bioprinting. The review also covered the applications related to tissue regeneration associated with discussed bioprinting methods compiled from different studies.

Figure 1: 
3D bioprinting applications.
Figure 1:

3D bioprinting applications.

2 Inkjet bioprinting

Inkjet bioprinting is a biofabrication approach and a non-contact method used to produce 3D printed constructs in a layer-by-layer form by depositing ink drops on successive layers. Inkjet printing allows very small droplets of multiple cells or proteins to deposit onto a targeted spatial position to generate a well-structured 3D printed construct [19]. The first inkjet printers were modified versions of commercially available 2D ink-based printers in which the ink in the cartridge was replaced with biological material and the paper was replaced with an electronically controlled elevator stage to provide control of the z-axis (the third dimension in addition to the x and y axes). The advantages of inkjet printing are high-throughput capability, high resolution, low cost, reproducibility, and ease of use. Moreover, inkjet printers can be easily modified for printing cells and biomolecules. However customized designed inkjet printers were used to handle and print biological materials at increasing resolution, precision, and speed [18, 20]. Roth et al. adapted inkjet printing technology to the complex field of tissue engineering. This research paper presented the adaptation of high-throughput inkjet printing to control cellular attachment, proliferation, and automated deposition of collagen. It was observed that cells began to proliferate, attach to the collagen surface, and reach confluency after 5 days. The research paper concluded that the inkjet technology could develop viable cellular patterns with a resolution of 350 µm by depositing collagen proteins into the cellular matrix, which resulted in printing flexibility and maintenance of biological properties [21]. To generate a 3D printed construct, the inkjet printers use thermal or acoustic forces which eject drops of liquid onto a substrate. Electrical heating of the print head is also performed in inkjet printing for generating pulses of pressure to eject the droplets from the nozzle. The advantages of thermal inkjet printers are high printing speed, low cost, and wide availability [22]. The limitations of thermal inkjet printing include its exposing cell materials to thermal and mechanical stress, low droplet directionality, non-uniform droplet size, frequent clogging of the nozzle, and unreliable cell encapsulation. The various inkjet printers use a piezoelectric crystal which is placed inside the printer head for creating acoustic waves to break the liquid into droplets at regular intervals. When voltage is applied to the piezoelectric material there was a rapid change in shape by the generation of pressure that ejected droplets from the nozzle [23]. Other inkjet printers utilize an ultrasound field to eject liquid droplets from an air-liquid interface through the generation of acoustic radiation force. The advantages of acoustic inkjet printers are the ability to control and develop uniform droplet size and direct ejection to avoid exposure of cells to heat and pressure stressors. However, the main advantages and disadvantages are shown in Tables 1 and 2 [20, 24, 25]. Figure 2 shows the schematic view of an inkjet-based bioprinter. 3D construct produced by an inkjet printer is an important area especially dealing with cellular patterns containing biological properties. However, 3D bioinkjet printers have extensive diversity in bioink composition but it requires more care to avoid damage of sample because application of this techniques is dropped by drop not continuous.

Table 1:

Advantages of different 3D printing techniques [20, 24], [25], [26], [27].

Inkjet bio-printing
Inkjet printing
  1. High-throughput capability

  2. High resolution

  3. Low cost reproducibility

  4. Ease of use

  5. Easily modified for printing cells and biomolecules

Thermal inkjet printing
  1. High printing speed

  2. Low cost

  3. Wide availability

Acoustic inkjet printing
  1. The ability to control and develop uniform droplet size to avoid exposure of cells

  2. The ability to control and develop direct ejection to heat, to avoid from pressure stressors


Extrusion-based bioprinting

Extrusion-based 3D printing
  1. The ability to deposit very high cell densities for the generation of complex structures

  2. The production of self-assembling spheroids have helpful for accelerated the tissue organization

Filament based
  1. Comparative low cost

  2. Better mechanical resistance

  3. Good resolution

  4. Ability to create complex scaffolds to design complicated drug delivery systems with tough geometries

  5. Possibility to fill liquid, solid, semisolid material at the same time

Syringe based
  1. Helpful for pharmaceutical industries to create drug delivery systems

  2. High drug loading profiles

  3. Easily operate at room temperature

  4. Complex drug delivery system with varied drug release profiles


Laser-assisted bioprinting

Laser-assisted 3D printing
  1. The ability to print small volumes of cell suspension with high resolution.

  2. Printing of high cell densities

  3. Printing of highly viscous hydrogels

Table 2:

Drawbacks of different 3D printing techniques [20, 24, 25, 28], [29], [30], [31].

Inkjet bioprinting
Inkjet printing
  1. Directly exposing the cells and materials to thermal and mechanical stress

  2. Low droplet directionality

  3. Non-uniform droplet size,

  4. Frequent clogging of the nozzle and unreliable cell encapsulation.

Thermal inkjet printing
  1. The thermal element temperature range lied between 100 and 300 °C that can cause cell damage

Acoustic inkjet printing
  1. Not suitable for highly viscous/concentrated bioinks


Extrusion-based bioprinting

Extrusion-based 3D printing
  1. Chances of cell viability are very low

Filament based
  1. Limited availability of commercial polymer fed materials

Syringe based
  1. Thermal degradation

  2. Inhomogeneous temperature distribution

  3. Syringe required to be filled repetitively causing interruptions in the building process

  4. Due to air presence in the syringe, the interruption creates during the process


Laser-assisted bioprinting

Laser-assisted 3D printing
  1. Limited capability to use many biomaterials to develop scaffolds

  2. Requires additional chemical modifications

  3. It has no nozzle, therefore difficult to deliver the material to the desired region

  4. No additional space for polymerization resulting wastage of material and increased cost

Figure 2: 
Overview on inkjet bioprinting. Heat induced bubble nucleation and piezoelectric actuator were used to inject the bioink through the micronozzle in thermal and acoustic inkjet bioprinting, respectively.
Figure 2:

Overview on inkjet bioprinting. Heat induced bubble nucleation and piezoelectric actuator were used to inject the bioink through the micronozzle in thermal and acoustic inkjet bioprinting, respectively.

3 Extrusion-based bioprinting

Extrusion-based bioprinting is a promising approach that fabricates 3D printed constructs with relevant size and shape by allowing the printing of living cells onto a target-specific position while incorporating them in a hydrogel. The extrusion-based bioprinting device consists of a syringe, nozzle, and pressure system in which cells or proteins are incorporated in a hydrogel and loaded into the micronozzle sterilized syringes before printing. The cell-laden hydrogel or cell spheroids are deposited onto the substrate by air pressure or a motorized plunger to fabricate a customized 3D design [24]. Figure 3 shows a schematic diagram of Extrusion based bioprinting. The pneumatic and mechanical dispensing systems are commonly used to extrude biological materials for 3D bioprinting applications. The main advantages of extrusion-based 3D printing are the ability to deposit very high cell densities and the production of self-assembling spheroids for the generation of complex structures and accelerated tissue organization. Main advantages of extrusion-based bioprinting are shown in Table 1 [24, 25], [26], [27]. One of the significant disservices of microextrusion bioprinting is the bending of cell structure and loss of cell feasibility that outcomes from the pressure used to oust the bioink. However, disadvantages of extrusion-based bioprinting are shown in Table 2 [25, 28], [29], [30], [31]. The study suggested that the extrusion-based bioprinting approach has the specialty to use for the viscous samples (bioink) with the requirement of continuous application of pressure.

Figure 3: 
Overview on extrusion-based bioprinting. Structures with great mechanical properties and print confirmation can be raised with extrusion-based techniques.
Figure 3:

Overview on extrusion-based bioprinting. Structures with great mechanical properties and print confirmation can be raised with extrusion-based techniques.

4 Laser-assisted bioprinting

Laser-assisted bioprinting (LAB) follows the principles of laser-induced forward transfer and initially was developed to print organs or living tissues. After the improvement in technology, laser-assisted 3D printing was successfully applied to biological materials, such as peptides, DNA, and cells. The LAB device consists of a pulsed laser source, an absorption layer that consists of ribbon, and a substrate in which multiple cells and biological components were incorporated onto an arbitrary surface by using laser beams to print living tissues or organs [20]. Before laser exposure, the transparent absorption layers are coated with biological materials (bio-ink) which incorporate the living cells and/or proteins. Then the absorption layer is focused on a laser beam to heat the cell suspension and eject cells into the substrate. In laser-assisted 3D printing, the absorption layer plays a vital role in preventing direct interaction between the laser and biological materials. The main advantage of LAB is the ability to print small volumes of cell suspension with high resolution. In this method, the printed droplet volume can be easily controlled from 10 to 7000 pL by adjusting the viscosity and thickness of the bio-ink layer. Moreover, the printing of high cell densities and highly viscous hydrogels is promising with LAB, whereas this is difficult and challenging in inkjet printing. The main advantages are given in Table 1 [24, 25]. Figure 4 shows a schematic representation of the laser-assisted bioprinting technique. The significant restriction of laser bioprinting is lower cell feasibility contrasted with other bioprinting strategies. Another downside is the tedious procedure of ribbon readiness. Moreover, the main disadvantages are mentioned in Table 2 [24, 25, 28]. Although laser-assisted 3D printing is free from contact to the sample as well as no requirement of nozzle followed by ribbon (absorption layer) preparation, the pace of the fabrication process is relatively fast as compared to the other techniques.

Figure 4: 
Overview on laser-assisted bioprinting. Nucleation is induced by laser energy which moves the droplets of bioink towards the substrate.
Figure 4:

Overview on laser-assisted bioprinting. Nucleation is induced by laser energy which moves the droplets of bioink towards the substrate.

5 3D bioprinted scaffolds fabricated by inkjet printers

As an advanced biofabrication scheme, this 3D cell-printing technique has yielded major developments in the field of tissue engineering and regenerative medicine. 3D cell-printing is a well-programmed and cell-favorable fabricating system that facilitates the creation of 3D living tissue equivalents with required shapes and structural design to recapitulate human tissue complexity. These tissue substitutes act as biologically functionalized equivalents in compliance with customized patient specificity. However, it was reported that the inkjet bioprinting technique is compatible with living and nonliving materials [32, 33]. Therefore, this section majorly covered the 3D bioprinted scaffolds fabricated applications related to bone, cartilage, microvascular, smooth muscles cells, different growth factors, complex heterogenous 3D constructs, organ printing, and topologically designed structures created by inkjet printers.

5.1 Bone

Three-dimensional (3D) printing is a potential technique for bone tissue engineering. Although, printable ink materials with attractive features such as structural interconnectivity, mechanical strength, regulated degradation rates, and the inclusion of bioactive ingredients are crucial for improved bone regeneration. According to the research study, long bone 3D printed construct created by using inkjet bioprinting has shown positive results in the field of tissue engineering. Gao et al. have implemented 3D inkjet printing technology to fabricate bone tissue using polyethylene glycol dimethacrylate (PEGDMA) as bioink and blended with bone marrow-derived mesenchymal stem cells (BM-MSC). To analyze the osteogenic potential of used bioink they further enhanced their study on HA and bioactive glass nanoparticles and evaluated the difference. In addition, they concluded that HA-based scaffold had shown more osteogenic potential as compared to scaffold fabricated with bioglass [34]. However, in human clinical preliminaries, researchers have also worked on tricalcium phosphate (TCP) powdered-based 3D printed scaffolds produced from inkjet printers. The designed scaffold was embedded in 10 different patients which have faced distinctive maxillofacial defects. Therefore, the resultant of the experimental work has shown a decrease in operating time, improvement in the effectiveness of the scaffolding, and its alliance with the surrounding bone along with its overall no unfavorable effect on those patients [35, 36]. Similarly, a Chinese researcher group has disseminated their clinical trial report on the utilization of 3D-bioprinted titanium scaffold to treat diverse maxillofacial bone deformities and mandibular osteotomy. Once more, they revealed shorter operation time and great appealing outcomes related to tissue engineering application [36]. Inzana et al. utilized 3D inkjet printing technology to fabricate collagen-calcium phosphate scaffolds for bone regeneration applications. For that purpose, they implemented enhanced formulations using inkjet printers, by blended collagen and binder solution to form collagen-calcium phosphate scaffolds. The cytocompatibility of the scaffold materials was analyzed with C3H/10T1/2 cells through XTT assay and bone formation was investigated for 9 weeks by implanting the 3D printed scaffold into a critically sized murine femoral defect model. The results showed that the addition of 0.25 wt% Tween into binder solution resulted in enhanced mechanical strength of prepared scaffolds. The Tween 80 incorporation followed by physiologic heat treatment also resulted in reliable inkjet printing of collagen solution and showed enhanced mechanical strength and cell viability. The addition of 1–2 wt% collagen with binder solution also enhanced the flexural strength and cell viability of prepared composites. They concluded that the inkjet-delivered collagen coupled with osteoinductive factors improved the bone healing efficacy of the 3D printed scaffolds evident by in vivo studies [37]. In the same way, Cooper et al. reported the spatial control of osteoblast differentiation of C2C12 cells using inkjet bioprinting technology. The C2C12 myogenic precursor cells were used for determining cell viability seeded with a density of 200,000 cells and cultured in a growth medium. Spatial control of osteoblastic differentiation of C2C12 cells seeded in BMP-2-printed patterns of the dermal matrix was demonstrated using alkaline phosphate (ALP) staining. It was observed that an average of 78.7% BMP and 69% noggin remained across all concentrations after 24 h printing and ALP staining increased with increasing the amount of seeded BMP-2. Moreover, the 3D constructs printed with BMP-2 showed new bone formation within 2 weeks after implantation, evident in in vitro study [38]. Fielding et al. prepared a 3D printed scaffold using TCP incorporated with silica oxide (SiO2), zinc oxide (ZnO) dopants and investigated its mechanical and biological properties. In this study osteoblast, cells were cultured, and results were evaluated on different days. The results showed that TCP incorporated with dopants showed increased density of pure TCP and an increase in compressive strength compared to pure TCP scaffolds. The MTT assay revealed that developed 3D printed constructs showed enhanced cell proliferation and a higher number of cell attachments to the surface by day 7. Moreover, the addition of SiO2 and ZnO dopants into TCP favored mechanical properties and also increased cellular proliferation for tissue regeneration [30]. In continuation to their work, they utilized β-tricalcium phosphate (β-TCP) scaffolds for preparing 3D scaffolds incorporated with zinc oxide (ZnO2) and silicon oxide (SiO2) dopants. In this study, the tissue formation was evaluated up to 16 weeks by implanting the prepared scaffolds into the bicortical femur defect murine model. It was observed that the mechanical interlocking between the implants and host tissue was enhanced after 4 weeks of implantation for both pure and doped samples. Moreover, the TCP scaffolds incorporated with SiO2 and ZnO dopants implied increased new bone formation compared to undoped samples owing to enhanced collagen I and osteocalcin formation. They also concluded that the neovascularisation of doped TCP samples was three times higher compared to pure TCP control, as confirmed by FESEM micrographs [39]. In another work, Wu et al. used a modified 3D printing method to develop highly uniform CS (CaSiO3, calcium silicate) and β-TCP (tricalcium phosphate) scaffolds for osteogenesis tissue engineering. Tissue formation was investigated by implanting CS scaffolds in a rat femur defect model. The results showed that prepared CS scaffolds using this modified 3D method have uniform scaffold morphology with controlled pore size and porous structure. Furthermore, the compressive strength of 3D printed CS scaffolds was found to be 120 times more than conventional polyurethane template CS scaffolds. The 3D printed CS scaffold showed improved bone formation and stronger deposition of type I collagen and ALP in bone matrix compared to the control, demonstrated by hematoxylin and eosin (H & E) staining and immunohistochemical analysis [40]. Therefore, 3D bioprinted constructs using inkjet printing especially for bone regeneration have one of key potential area in the field research that can create more avenues in the field of 3D bioprinting.

5.2 Cartilage

Bone and cartilage transplant-designed tissues are more appealing as new tissue bones and cartilages may eventually be repaired, maintained, and enhanced. But the strategy of tissue cartilage engineering has remained difficult to imitate the characteristics of an extracellular tissue-specific matrix (ECM) and the cellular zone organization. It is reported that inkjet bioprinting is compatible with high-performance and resolution biological systems [41]. Hence, Xu et al. developed 3D printed constructs using a novel hybrid inkjet printing system for cartilage tissue engineering applications. The novel hybrid system had an electrospinning apparatus and printing solution. In this work, cell viability was evaluated. The results showed that the chondrocytes had more than 80% cell viability within the hybrid construct after one week of printing. Further, the printed hybrid scaffolds showed enhanced mechanical properties, cell proliferation, and maintained biological properties compared to conventional printers noted in both in vitro and in vivo experiments [19]. In another work, they studied the effect of fibroblast growth factor-2 (FGF-2) and transforming growth factor-beta1 (TGF-β1) on human neocartilage formation. It was found that the FGF-2/TGF-β1 treated samples showed enhanced cell proliferation of 40% compared to TGF-β1 treated group while the TGF-β1 treated group exhibited higher chondrogenic gene expression at week 1 compared to FGF-2 and FGF-2/TGF-β1 treated groups. Further they suggested that the 3D printed sample with FGF-2/TGF-β1 observed high ECM formation and possessed better chondrogenic properties suitable for tissue formation [42]. The results from the studies on 3D bioprinted cartilage construct using inkjet bioprinting technique revealed that inkjet printing technique played a significant role in bone cartilage and ECM formation including enhancement of mechanical and cell proliferative properties.

5.3 Microvascular

Although several alternative techniques for the creation of biomimetic cell environments have been established, however, the absence of vascularization in the 3D model is one of the primary concerns related to tissue engineering technology [43, 44]. In addition, a significant proportion of tissues in the body are supplied by nutrients and oxygen to the cells through blood vessels, as oxygen is around 100–200 μm at the diffusion limit [44, 45]. It is reported that microcirculation is the distal functional unit of the vascular system, based on the microvasculature. A vessel with varied sizes includes arterial (±30 μm), venous (±20 μm) and capillary (<8 μm) arterioles [44, 46]. It is also notified that there is a high potential for nerve tissue regeneration and functional restoration for biofabricated nanostructured and microstructured scaffolds. Furthermore, revascularization and transport are important features in the 3D fascicle structure. Unfortunately, the human peripheral nerves do not have a perfect internal fascicle and microvascular model [47]. Therefore, this section explained applications related to microvascular 3D printed scaffolds by using inkjet printing. Nakamura et al. reported the biocompatible inkjet printing technique for seeding individual living cells. In this investigation bovine vascular endothelial cells were used as “bioink” suspended in a culture medium and injected onto a PET sheet culture disk. The cell printing system used in this investigation was static electricity with actuated inkjet printers. The paper concluded that cells adhered to the culture medium within a few hours after incubation and the electrically actuated inkjet printers were biocompatible which does not produce a heat printing process and is suitable for color printing [48]. In an extension study, they utilized thermal inkjet printers for fabricating human microvasculature by printing human microvascular endothelial cells (HMVEC) onto fibrinogen biopaper substrate. The cell viability was analyzed after 24 h, 7, 14, and 21 days of printing. The results showed after 21 days of culture the printed endothelial cells proliferate to form a confluent lining within the fibrin scaffold. The fabricated microvascular cells showed some integrity after being cultured for 14 days and much integrity was observed from the printed cultured for 21 days [49]. In this part, two different types of inkjet printing techniques have been discussed (actuated and thermal), both types have shown optimistic characteristics for the regeneration of microvascular structure.

5.4 3D patches using smooth muscle cells and different growth factors

The capacity to bioengineered 3D tissues is a possible method to treat a range of illnesses such as cancer, tissue loss, or organ failure. However, traditional approaches for tissue engineering have encountered problems in building 3D tissue constructions similar to the microvasculature and microarchitectures of the natural tissue [50]. Growth factors stimulate strong regulations on cell function in strategy for the production of tissues, but it is difficult to spatially shape their presentation in 3D using a single substance [51]. This part defines the utilization of smooth muscle cells and different growth factors to fabricate 3D patches for tissue regeneration applications. Moon et al. developed 3D patches of smooth muscle cells (SMC) using a bio-printer blended with collagen. In this work the bioink used was SMC cells derived from Sprague Dawley rats while the substrate was collagen to deposit the cell-laden structure. The experimental results revealed that the hydrogel constructs were formed at 16.2 µm thick per layer with controlled spatial resolution, high-throughput droplet generation with 160 droplets/s per layer and high cell seeding uniformity about 26 ± 2 cells/µm2 at 1 million cells/mL, 122 ± 20 cells/µm2 at 5 million cells/mL and 216 ± 38 cells/µm2 at 10 million cells/mL respectively. Moreover, it was also found that multilayered 3D hydrogel constructs exhibited high cell viability of about >90% over 14 days in culture [52]. Lee et al. reported the time-release delivery of growth factor (GFs) in hydrogel tissue constructs for neural stem cell culture. In this investigation, the artificial neural tissue was developed by printing neural stem cells (C17.2) within collagen hydrogel and vascular endothelial growth factor (VEGF) releasing fibrin gel using 3D techniques. They examined the morphological changes of C17.2 cells within collagen and its migration towards fibrin gel. They observed that murine NSC C17.2 cells with VEGF fibrin gel exhibited a high degree of morphological changes compared to control samples for up to 3 days. It was observed that the printed C17.2 cells with VEGF fibrin gel showed high viability of about 92.89 ± 2.32% and that cells migrated towards the fibrin gel at a distance of 33.3 ± 18.2 µm on day one, a distance of 34 ± 45.2 µm at day 2 and a total migration distance of 102.4 ± 76.1 µm over 3 days respectively [53].

In the extension study, they printed the human chondrocytes in layer-by-layer (LBL) assembly to repair defects in osteochondral plugs (3D biopaper). The bioink was prepared by chondrocyte cells isolated from human articular cartilage at a density of 5 × 106 cells/mL The prepared bioink was deposited into the OC plug biopaper with a suspension of 5 × 106 cells/mL using a modified HP Inkjet 500 printer. It was observed that the cell viability of 3D printed constructs increased 26% in simultaneous polymerization compared to polymerization after printing and printed 20% w/v PEGDMA showed reduced compressive modulus by 18% compared to non-printed PEGDMA. Further, it was noted that the printed samples exhibited an increase in glycosaminoglycans (GAG) and collagen II formations, and the formation of CAG/DNA and collagen II/DNA by chondrocytes at week 4 were both significantly higher than those of implant constructs without OC plugs (evident in biochemical analysis). They also concluded that the printed human chondrocytes showed enhanced ECM deposition and phenotype maturation in native tissue [49]. In another study, Phillippi et al. developed spatially defined 3D patterns of immobilized growth factors using inkjet and bioprinting. In this study, the bioink used was recombinant human BMP-2 and the substrate was fibrin coated glass. To investigate cell viability two types of cells were analyzed, namely primary muscle-derived stem cells (MDSCs) and C2C12 cells added with growth factors (noggin and FGF-2) and were printed onto a fibrin-coated glass substrate. Before printing the liquid phase BMP-2 patterns were subjected to alkaline phosphate activity (ALP) for 72 h. The results showed that noggin inhibited BMP-2 pattern response in both MDSC’s and C2C12 cells whereas FGF-2 partially inhibited BMP-2 responses in MDSC and inhibition was completed in C2C12 cells. Both MDSC and C2C12 cells showed differentiation towards the osteogenic lineage by ALP activity and concluded that cells with APL activity (on the pattern) differentiated toward the osteogenic lineage whereas cells without APL activity (off pattern) differentiated toward the myogenic lineage [54, 55]. Ferris et al. developed 3D scaffolds using bioink-based novel microgel suspension into the tissue culture medium. In this study, the bioink used was endotoxin-free low acyl gellan gum with a density of 2 × 105 to 2 × 106 cells/mL for microvalve printing and 1–6 × 106 cells/mL for inkjet printing into rat tail collagen I biopaper. In this research study, the cell viability was investigated using C2C12 (CRL-1772), PC12 (CRL-1721), and L929 (CCL-1) murine cell lines derived from ATCC. The results showed that the bioink exposed to C2C12 and PC12 cells does not have any cytotoxic effect. Moreover, the viability of bioink exposed to PC12 cells was significantly higher compared to other cells. Ink-jet printed PC12 cells and both inkjet and microvalve printed C2C12 cells retained >95% viability and proliferated for more than 48 h at a rate comparable to non-printed controls [56].

Cui et al. evaluated the cell viability, apoptosis, and possible cell membrane damage of thermal inkjet printed Chinese hamster ovary (CHO) cells. In this work the bioink used was CHO cells suspended with a density of 2 × 106 to 20 × 106 cells/mL and were loaded into rat tail collagen type I biopaper using thermal inkjet printers. It was found that the thermal inkjet printed CHO cells showed improved cellular viability of about 89%. Further, it was observed that the number of cells printed decreases with an increase in the concentration of bioink and the highest number of cells printed was seen at 8.2 × 106 cells/mL concentration. Further, the apoptosis ratio was found to be 3.5 ± 1.3% for printed cells and 3.2 ± 1.6% for unprinted cells which showed that the thermal printing process would not affect the cells compared to normal handling [57, 58]. Similarly, Zhao et al. investigated the effect of printing parameters on the printability and cell survival rate in fabricated constructs using 3D technology. The cell viability was investigated using A549 cell lines and the cell-laden 3D printed construct was fabricated by suspending the cells in a bioink solution with a density of 106 cells/mL. The results showed that bioink viscoelasticity was increased with the bioink concentration, increasing holding time and decreasing holding temperature below gelation temperature. Cell survival rate was decreased upon increasing the viscoelasticity of the gelatin-based bioink. It was also found that high cell survival rate and optimum printability were achieved at bioink storage modulus in the range of 154–382 Pa respectively [59].

In extension work, they used a thermal printer to deposit CHO and embryonic motor neuron cells into a hydrogel-based substrate. In this research, two hydrogel-based substrates were used as a biopaper, named soy agar gel and collagen gel. The cell viability was evaluated. It was found that the 3D printed samples using both cells showed cell viability of >90% and that the cells were not damaged during nozzle firing in the inkjet printing process [60, 61]. The above different experimental examples have shown a broad impact of inkjet bioprinting technique using smooth muscle cells and different growth factors in the area of 3D bioprinting for tissue engineering applications. Therefore, 3D patches based on smooth muscles cells and growth factors using inkjet bioprinting is an important area that needs to do more work to create new ways of research in the tissue engineering region.

5.5 Complex heterogeneous 3D tissue construct

The capacity to produce functioning tissue additives is now providing novel alternatives to existing tissues and organs shortages needed for transplantation [62]. However, the development of artificial tissues and organs completely functional has for many reasons which are not fulfilled expectations [63]. Therefore, Xu et al. developed complex heterogeneous 3D tissue constructs using inkjet printing of multiple cell types. In this study the bioink used was human amniotic fluid-derived stem cells (hAFSCs), canine smooth muscle cells (dSMCs), and bovine aortic endothelial cells (bECs). They were suspended with a density of 2–3 × 106 cells/mL and deposited onto sodium alginate biopaper using thermal inkjet printers. The biological functions of the 3D printed constructs were evaluated in vitro and in vivo. The in vitro results showed that 3D printed cells survived and proliferated with normal cellular function in spatial registered regions. The viability of cells was 90% over 7 days and there was no significant difference in viability between printed and unprinted samples [63]. The author introduced the novel cellular hydrogel biopaper approach with improved cell culturing, handling, and assembling features which can lead to help in the improvement of studies for 3D bioprint scaffolds for future developments in tissue engineering.

5.6 Organ printing

3DP, recognized as the most exciting bio-artificial organ production technique, has offered remarkable adaptability when supplying multifunctional cells together with other biomaterials through accurate spatial placement control. The continual development of 3D printing technology is the integration of biomaterials in biology, chemistry, physics, mechanics, and medicine with other related methods. In the support of cell and biomolecular (or bioactive agent) activities before, during, or following 3D printing, synthetic polymers played an important role. Biodegradable synthetic polymers are particularly preferred options for the production of bioartificial organs with good mechanic characteristics, adjustable chemical structures, non-toxic degradation products, and controlled rates of breakdown [64], [65], [66]. Therefore, this section has described 3D organ printing applications using inkjet bioprinter. Hajdu et al. developed a 3D printed construct based on self-assembling tissue spheroid and fusion kinetics for organ printing. In this work, the tissue spheroid biofabrication was done using bone marrow cells from periostin-null mice and adult murine cardiac valve interstitial cells from C57BL/6 mice. The result showed that both TGFβ1 and serotonin treatment exhibited fibrogenic and maturogenic effects in a tissue spheroid assay compared to controls. It was also found that the length of the fusing aggregates and the interface between them was decreased much faster in tissue spheroids fabricated from periostin-null fibroblasts compared to wild-type mice [67]. Hence, organ printing using inkjet printing has acquired positive results on organ printed constructs, especially due to its favorable microenvironment for new tissue regeneration.

5.7 Topologically designed structures for tissue engineering

Recent advancements have led to the notion of bioprinting becoming an attractive alternative to established methods associated with tissue technology. Biopaper is an important component in the bioprinting process and biomimetic hydrogel [68]. Hence, this part described the applications related to biopaper hydrogel using the inkjet bioprinting technique. Lee et al. developed a cellular hydrogel biopaper for patterning 3D cell culture and tissue reconstruction. In this investigation, the cellular biopaper was prepared using 0.5% sodium alginate precursor and 5% w/v gelatine in PBS and sterilized overnight by germicidal UV irradiation. The results also showed that during days 2–4 of culturing both Hexa and Flat biopaper showed significantly increased cumulative albumin secretion compared to 2D culture. Also found Hexa biopaper had even higher albumin secretion than that of Flat biopaper [69]. Similarly, Jakab et al. reported the biological self-assembly of cells printed into topologically designed structures for tissue regeneration. In this method, the bioink particles were placed into a bio-compatible environment (biopaper) supported 3D delivery system (bioprinter). The 3D structures were formed through the post-printing fusion of bioink particles into the biopaper. In this study fusion of the bioink particles was done by atrioventricular (AV) cushions extracted from chicken embryonic heart and were deposited into rat tail collagen biopaper using inkjet printers. They concluded that the fusion deposition of bioink particles into the gel-biopaper showed smooth deposition of cellular aggregates and cell movement for tissue regeneration applications [70].

In 3D inkjet printing, the 3D printed constructs were fabricated by printing the bioink suspension into the biopaper. The bioink used was a cell suspension supported by growth factor; enhanced cell viability and proliferation for tissue growth were observed compared to scaffolds without growth factors. The 3D printed constructs with growth factors like FGF-2, TGF-β1, or FGF-2/TGF-β1 showed ECM, collagen content, and high GAG for cell growth and new tissue formation. Many researchers used sodium alginate gel and collagen I as biopaper and utilization of other hydrogels was found less common. Some studies have investigated the fusion of bioink particles before post-printing of the cell suspension into biopaper; a tissue spheroid development and smooth deposition of cellular aggregates and cell movement for tissue regeneration applications have been observed [71]. Inkjet bioprinting is commonly used more as compared to other printing techniques. However, from the investigated results inkjet bioprinting technique in different applications of 3D printed scaffold design. It provides better growth factors, mechanical strength, bone healing efficiency, increases cell viability, improved cell morphology, maintains biological properties, improved biocompatibility, and enhanced ECM deposition.

6 3D scaffolds prepared by extrusion-based 3D printing

3D cell printing technology has owned the unique flexible approach for making tissue/organ substitutes. Through the deposition of cell-laden bioink in a precise manner, various anatomical structures of the desired tissue/organ and its equivalents can be fabricated, as the particular cells, development and functional tissue regeneration occurred [72]. One of the important types of 3D printing technology is the extrusion-based bioprinting technique also called direct writing. Recently, it has been broadly involved in the field of biofabrication and tissue engineering [32]. Therefore, this section described different 3D printed scaffolds constructed by extrusion-based 3D printing.

6.1 Heterogeneous tissue regeneration

New types of printers have been developed to achieve functional engineered tissue constructions as the field of tissue engineering advances. However, new 3D biomanufacturing methods for hard tissue and organ engineering are uncommon, and there are numerous constraints in terms of equipment. One of the most promising tissue engineering methods, according to recent research, is the creation of heterogeneous 3D structures. However, the creation of heterogeneous tridimensional scaffolds is heavily reliant on a variety of biomanufacturing methods and technologies [73]. Pati et al. developed 3D cell-laden scaffolds for heterogeneous tissue regeneration using a 3D printing technique. In this work, complex ear tissue constructs were fabricated using synthetic biomaterial polycaprolactone (PCL) as a framework and PEG as a sacrificial layer. The live/dead assay was used to examine the viability of encapsulated cells in the hydrogels. The results showed that the 3D printed constructs were prepared using biomaterials signaled enhanced thermal stability and also improved cell viability of >95% in all cases of hydrogels [74].

In another work, Lee et al. utilized a sacrificial layer process via a 3D technique to regenerate damaged auricular cartilage and fat tissue. In this work, the main framework was fabricated using PCL to deposit the cell-laden hydrogel and further PEG was also deposited as a sacrificial layer to support the main structure. The chondrocytes (CLH) and adipocytes (ALH) are derived from adipose-derived stromal cells. The results showed that the CHL-AHL incorporated hydrogel 3D structure exhibited enhanced collagen formation and also increased the co-regeneration of cartilage and fat tissue compared to individual printed CHL and AHL structures suitable for ear regeneration [75]. In the future, we aim to utilize other hydrogels for fabricating 3D printed constructs that favor tissue regeneration.

6.2 Bone

The regeneration of bone and bone impairment has remained one of the primary challenges in clinical medicine, despite progress in the therapeutic methods since the healing and repair processes are long term and extremely intricate [76]. To solve these issues, research work reported the limited biological functionality of typical mode synthetic materials. In this study, human turbinate mesenchymal stromal cells (hTMSCs) mineralized with ECM were deposited into the 3D printed scaffolds prepared from synthetic materials of PCL, poly (lactic-co-glycolic acid) PLGA, and β-tricalcium phosphate (TCP). The cell viability was evaluated with a cell density of 2 × 105 cells/mL deposited onto a PCL/PLGA/β-TCP scaffold using a multiheaded deposition system (MHDS). The in vivo results showed that ECM-ornamented scaffolds showed higher biological functionality and bone formation compared to bare 3D printed scaffolds. The new hTMSC mineralized ECM showed higher calcium deposition compared to bare 3D printed scaffolds. They concluded that ECM ornamented scaffolds exhibited both osteoinductive and osteoconductive properties for increased tissue formation and bone regeneration [77]. In the continuation work, they fabricated a 3D bioprinted construct with improved mechanical properties for osteochondral tissue regeneration. In this work, thermoplastic PCL was used as a framework and the cells encapsulated with alginate hydrogels were deposited into the pores of the PCL framework using an MHDS. The cell viability was tested by a Live/dead assay kit with two types of cells, chondrocytes and MG63-osteoblast cells derived from a human cell line. The results showed that the 3D constructs deposited with chondrocytes and osteoblast cells remained viable for 7 days without fusion. The research study also revealed that the fabricated 3D printed scaffold using PCL and alginate hydrogel improved the mechanical stability of prepared 3D printed constructs and had the potential for the regeneration of heterogeneous tissues [78]. In an extension study, they also fabricated guided bone regeneration (GBR) using 3D printing technology. The GBR membrane was based on PCL/PLGA/β-TCP composites and investigated the profile release of recombinant human BMP-2 (rhBMP-2). It was observed that the hybrid composites showed sustained release of rhBMP-2 for up to 28 days. The implantation of rhBMP-2 with GBR membrane resulted in the entire healing of calvaria defects and new bone formation within 8 weeks [79]. Holmes et al. developed 3D printed micro and nano featured scaffolds for vascularized bone tissue repair. Polylactic acid (PLA) was used as a framework and the PLA scaffold was printed on a solidoodle fused deposition modeling (FDM) printer layer by layer with 250 μm diameter, hexagonal pore size, and a 375 μm layered height. The results showed that the modification of nHA on both cells enhanced cell adhesion and calcium and collagen I content during osteogenic differentiation. It was found that enhanced human mesenchymal stem cells (hMSC) adhesion and growth were observed on scaffolds with small microchannel and nHA modification while scaffolds with large channels promoted the greatest HUVEC growth [80]. Fedorovich et al. developed a cell-laden hydrogel scaffold by the 3D fiber deposition technique. In this study, the hydrogel scaffold was prepared using high viscosity alginate powder crosslinked. The results showed that increased scaffold porosity resulted in a decrease in elastic modulus of the prepared scaffolds. The 3D printed MSC showed uniform cell distribution and high viability of about 88 ± 6% and 89 ± 7% in the printed group and the unprinted group, respectively, after 24 h in culture. They also suggested that osteochondral grafts exhibited heterogeneous ECM formulation within the scaffold, evident by the presence of a high amount of collagen matrix in cellular grafts that resulted in enhanced osteogeneic tissue formation [81]. Tarafder et al. reported the biological performance of interconnected macroporous TCP scaffolds with the addition of SrO and MgO dopants and their effects in TCP. In this research, the scaffolds were prepared on different three different interconnected pore sizes through 3D technology followed by microwave sintering. An in vivo study was performed by implanting a developed macroporous scaffold in a rat distal femoral bone. It was observed that the sintered pure and Sr-Mg doped TCP scaffolds showed pore sizes of about 311 ± 5.9 µm and 245 ± 7.5 µm. The maximum compressive strength of 12.01 ± 1.56 MPa was obtained for Sr-Mg doped with 500 µm interconnected designed pore sizes. Also, SrO and MgO doped 3D printed scaffolds have shown improved type I collagen and osteocalcin formation that resulted in a significant increase in bone formation, evident by histomorphology and histomorphometric analysis [82]. In the extension work, they fabricated and investigated microwave sintered TCP scaffolds of 27, 35, and 41% designed macroporosity with different pore sizes. The in vitro testing was investigated using human fetal osteoblast cells (hFOB) at 3, 7, and 11 days of incubation and revealed that the smallest designed pore size (500 µm) shows significantly high living cell density. It was observed that the sintered 3D printed scaffolds have shown enhanced compressive strength and maximum compressive strength for scaffolds designed with 500 µm pore size. Further, the sintered 3D printed TCP scaffolds promoted osteoid-like new bone formation evident in histomorphologic analysis and suitable for bone tissue repair and regeneration [83]. In the same way, Santos et al. studied the characteristics of sintered β-TCP scaffolds encapsulated with human osteoblast cells. In this study, the fabricated (β-TCP) scaffolds were sintered at four different temperatures. The results showed that sintered (β-TCP) 3D printed scaffolds have shown increased biocompatibility with enhanced mechanical properties and cell scaffold interactions of human osteoblast cells revealed by SEM images and in vitro or LBL cytotoxicity assay [84].

Kundu et al. fabricated 3D constructs through the layer-by-layer deposition of PCL and chondrocyte cells encapsulated with alginate hydrogels. In this study, the 3D printed scaffolds of the PCL-alginate gel hydrogel hybrid construct were prepared by additive manufacturing (AD) with an MHDS. The results showed that the cell-laden hydrogels had negligible effects on the viability of the chondrocytes. In vitro assessments revealed that the PCL-alginate gels containing growth factor (TGF-β) showed higher ECM and GAG content after 4 weeks of implantation in engineered cartilage. This suggests that TGF-β has a significant effect on tissue response for cartilage regeneration [85].

In another work, Shao et al. reported the mechanical behavior of bioactive glass-reinforced bioceramic scaffolds using a 3D method. In this study, the scaffolds were prepared using bioactive glass (BG) incorporated with CS components. They prepared 1% BG-added CS scaffolds with various pore morphologies. In this study, the 1% BG-added CS scaffolds were printed with rectangular, parallelogram, honeycomb, and Archimedean chords pore structures using extrusion-based three-dimensional printing and characterized using optical microscopy. The results showed that the 1% BG-added CS scaffolds designed with rectangular pore morphology (1080 °C) had very low BG content which readily influenced the apatite formation and significant linear shrinkage (21%) respectively. From experimental results, CS-BG1 scaffolds designed with honeycomb pore structure showed an enhanced compressive strength of 88 MPa compared with the scaffolds with rectangular, parallelogram, and Archimedean chord pore structures. In vitro, SBF experiments revealed that BG reinforced CS scaffolds favored the formation of hydroxyapatite (HA) and contributed to structural and strength reliability in the long term [86]. Calcium silicate (CSi) and TCP were the most widely used materials for the fabrication of 3D scaffolds. To increase the mechanical strength and cell proliferation the addition of dopants like SiO2 and ZnO was used. It was also concluded that the sintered samples possess high mechanical properties and controlling parameters such as particle distribution, sintering temperature and sintering time, the porosity, bulk density, and compression strength of fabricated scaffolds. These scaffolds significantly enhance new bone formation [87]. Recently Chae et al. worked on 3D cell-printed meniscus constructs, introduced by the new combination of bioink based on polyurethane and polycaprolactone polymers and cell-laden decellularized meniscal extracellular matrix (me-dECM) bioink with improved structural and controlled properties. They reported that (decellularized meniscal extracellular matrix) me-dECM bioink had the deeper capability to deliver a satisfying physiological environment for the cell growth and fibrochondrogenic differentiation of encapsulated human bone-marrow-derived MSCs (hBMMSCs, Catholic MASTER Cells, passage 2). They examined in vivo testing comprehensively on the ectopic mouse and orthotopic rabbit models and verified that the designed 3D cell-printed meniscus construct containing me-dECM bioink with stem cells has shown improved biocompatible features and supported the development of neofibrocartilage with strong mechanical properties which were like the native meniscus. From the outcome of the study, they concluded that the combination of 3D cell-printing technology and me-dECM bioink have developed a better shape and microenvironment characteristics to enable the growth of meniscus [88]. Chae et al. also worked on the tendon-bone interface (TBi). For the regeneration of functional TBi, they have established a new therapeutic system consisting of 3D cell printing and its related bioinks to attain spatially categorized physiology. The spatial composition of cell-laden tendon and bone-related bioinks was used to create an interface like multi-tissue fibrocartilage. The designed 3D TBi printed scaffold presented a cell supportable microenvironment of encapsulated stem cells in terms of cell viability, proliferation, differentiation for in vitro development of TBi. In vivo characteristics were also investigated on rat chronic tear model with 3D TBi constructed patch along with stem cells. The outcome revealed positive sign on TBi healing process. Therefore, the research has proven the new therapeutic approach for functional TBi regeneration using 3D cell-printing and tissue-specific decellularized extracellular matrix (dECM) bioink-based strategy [89]. Different investigations results revealed that utilization of 3D bioprinting techniques have a big impact on the field of tissue engineering using dopants specially to enhance following properties mechanical, biocompatibility, biodegradability, cell viability, cell proliferation, longevity, bone formation, less cytotoxicity.

6.3 Other applications for 3D printing

Despite advances in treatment methods, the healing and repairing of bone injuries and abnormalities has remained one of the most prevalent issues in clinical medicine because the healing and repairing processes are long-term and extremely difficult [90].To this aim, tissue engineering can heal different tissues using artificial biological replacements that restore the form and function of damaged tissue defects or malfunctioning organs [76, 91]. Therefore, this part explained other advanced applications related to extrusion-based 3DP. Shim et al. developed a 3D hybrid scaffold through solid freeform technology containing synthetic biomaterials and natural hydrogel. In this work the hydrogel was deposited into the space of a synthetic biomaterial-based scaffold using a multi-head deposition system (MHDS) and the cellular efficacy of the hybrid scaffold was evaluated using rat primary hepatocytes and mouse pre-osteoblasts (MC3T3 E1 cell line). In this research the synthetic biomaterial used for fabricating the scaffolds were PCL, PLGA, PCL/PLGA (85:15 wt%) and natural hydrogels were hyaluronic acids, gelatine, and atelocollagen. The results showed that the developed 3D hybrid scaffold had a superior effect on cell adhesion, proliferation, and viability of dispensed cells. They also revealed that collagen blended with the PCL/PLGA scaffold showed enhanced adhesion and proliferation of hepatocytes in 3D printed scaffold compared to other hydrogels and also improved cell viability of hepatocytes [92].

Domingo et al. reported the mechanical and biological performances of poly (e-caprolactone) scaffolds using extrusion-based 3D printing technology. In this work, three different lay-down patterns were adopted (0°/90°, 0°/60°/120°, 0°/45°/90°/135°) for fabricating the 3D printed scaffolds thus resulting in quadrangular, triangular and complex polygonal internal geometries. The cell seeding experiments were carried out using hMSC suspended at a density of 17 × 103 cells/mL and were deposited onto PCL scaffolds. The cell viability and proliferation were investigated for 21 days and the SEM micrographs of PCL scaffolds were characterized by different lay-down patterns. The fabricated 3D rapid prototyped scaffolds had pore sizes and porosity ranges of 245 µm and 49–57%, respectively. Further, the mechanical and compression tests revealed a decrease in scaffold stiffness with increasing the porosity and number of deposition angles (from 0°/90° to 0°/45°/90°/135°). It was also revealed that hMSC viability/proliferation was enhanced after 21 days influenced by the pore size and shape of the scaffold. However, observed increment in cell viability with the decreasing number of deposition angles, larger fiber diameters, and pore sizes [93].

Seyednejad et al. fabricated 3D printed scaffolds based on hydroxyl functionalized polyester (poly (hydroxyl methyl glycoside-co-ε caprolactone) [PHMGCL]) through fiber deposition. In this study, 3D printed scaffolds of PHMGCL and HMG: CL (8:92 wt%) were prepared by fiber deposition (melt-plotting) and compared with poly(ε-caprolactone) PCL scaffold. The biodegradation and biocompatibility of PHMGCL and PCL scaffolds were investigated after 4 and 12-weeks post-implantation in balb/c mice. The in vitro enzymatic assay revealed that the degradation weight loss of PHMGCL 3D printed scaffolds were more than 60% within 3 months while PCL scaffolds showed no weight loss in the time frame. Further, the PHMGCL scaffold was degraded within 50 h while the PCL scaffold degradation was observed after 72 h, as noted in NMR analysis. Further, the PCL scaffolds showed an increased number of cells after 3 months of implantation and indicated milder tissue response to PCL scaffolds compared to PHMGCL scaffolds. The research concluded that the fast degradable PHMGCL scaffold showed good biocompatibility and could be a promising biomaterial for tissue engineering applications [94]. Billiet et al. reported the cell viability of a macroporous 3D printed scaffold using gelatin methacrylamide. Three-dimensional porous scaffolds were produced by sequential fiber deposition using the plotter pneumatic dispensing system. It was also observed that the cell viability of conical-type needles was found to be higher than cylindrical-shaped needles and a further decrease in viability with an increase in pressure level. The 3D printed constructs were fabricated using VA-086 initiator displayed high cell viability >97%, which can be suitable for tissue regeneration [95]. Rajaram et al. reported the effect of hyaluronic acid (HLA) and polycation polyethyleneimine (PEI) on alginate hydrogels in terms of physical properties. The cell culture was analyzed using ATDC5 chondrogenic cells derived from mouse genic and rat Schwann cells. It was suspended in alginate-hydrogel solution at a density of 1.6 × 106 cells/mL to generate a cell-laden hydrogel construct using Bioplotter. The observed results showed that encapsulated Schwann cells and ATDC5 maintained cell viability for long periods and tended to show reduced cell survival at higher PEI concentrations. The addition of HLA to alginate increased the viscosity of hydrogel and helped to attain good strands during 3D plotting. They reported that there was no significant increase in mechanical properties even after increasing the PEI concentration by five-fold. Further, they concluded that increasing the concentration of PEI in crosslinking solution resulted in a decreased percentage loss or degradation of scaffolds [96]. Skardal et al. fabricated photo-crosslinked alginate-HLA 3D printed constructs were based on HLA-MA: GE-MA hydrogels for tissue engineering. In this work, the HA was synthesized using methacrylic hyaluronic acid to form HLA-MA, whereas the gelatine was cross-lined with methacrylate ethanolamide to form GE-MA. As a result, gel-like fluid was extruded by partial photochemical co-crosslinking of GE-MA with HLA-MA. The cells used for investigation were HepG2 C3A, Int-407, and NIH3T3 and they were seeded into HLA-MA: GE-MA hygrogels with a density of 25,000 cells per 100 µL hydrogel to develop cell laden constructs using Fab@ Model 1 Bioprinter. In this system the partially crosslinked hydrogels were extruded from a syringe into a designed base layer and irradiated again to create a firmer cellular tubular structure with cell-free core and cell-free structural halo. The printed cells with HLA-MA: GE-MA hydrogels showed enhanced presence of collagen and procollagen compared to cell free hydrogels. Moreover the fabricated HLA-MA: GE-MA hydrogels by two step photo crosslinking showed both cytocompatible and biocompatible properties in vitro and in vivo [97]. Zhang et al. fabricated a strontium-mesoporous bioactive glass (Sr-MBG) scaffold using 3D printing technology. In this study, a 3D bioplotter was used to print the Sr-MBG scaffold and the cell response of the MC3T3-E1 cell line on the Sr-MBG scaffold was investigated. The cell culture study was performed by seeding 1 × 105 cells/mL on each Sr-MBG scaffold. The cell viability of MC3T3-E1 cells was determined by the Cell Counting Kit-8 assay. The study result reported that printed 3D Sr-MGB scaffolds had uniform interconnected macropores and higher porosity. The number of cells attached to the Sr-MGB scaffolds was observed to be higher than that of MGB scaffolds. Further, the Sr-MBG scaffolds showed a sustained drug delivery property with dexamethasone (DEX) drugs owing to its mesoporous structure. It was also observed that 75–85% of the loaded DEX was released from Sr-MBG scaffolds on day one which was followed by a very slow release thereafter [98].

Huang et al. utilized the 3D printing technique for designing complex drug release profiles and compared them with conventional mold techniques. The prepared drug implants were characterized using SEM and UV absorbance spectrophotometry. It was found that the implants prepared by 3D printing achieved both distinct bi-modal and pulsed release profiles in a single implant compared to conventional techniques. Moreover, the pulse release appeared from day 5 to 25 with a steady-state phase of 25 days. The next pulse release phases began at day 50 and ended at day 80; the steady-state profile release was observed at 5 µg/ml of LVFX [99].

In another research work, Chung et al. fabricated 3D scaffolds using additive biofabrication (3D bio-printing). In this study alginate (Alg) was preferred as a bioink for printing the cells. The structure of the printed Alg-gel scaffold. It was found that pre crosslinked alginate formulation, consisting of alginate and CaCl2, was not stable during extrusion and resulted in liquid-like scaffolds with inconsistent pore diameters. The added gelatin improved the printability with well-defined structures and pore diameters. The in vitro degradation tests showed a 50% drop in modulus after 4 days which further decreased to more than 80% after 14 days, indicating the enhanced stability of printed cells. Live/dead cell assay showed that myoblast viability of about 90% was maintained within Alg-Gel scaffolds for 48 h and was unaffected by all extrusion pressure levels [100]. Suwanprateeb et al. used hydroxyapatite and Bis-GMA (bisphenol A diglycidyl ether dimethacrylate) for making composites via 3D printing. In vitro cell toxicity was performed using human osteoblast cells by seeding 10,000 cells/mL into HA/Bis-GMA scaffolds. The results showed that the sintered 3D samples possessed higher hydroxyapatite content, high density, and greater modulus but the strength and strain at break points were found to be lower compared to the green 3DP (nontoxic) sample. In vitro cell toxicity revealed that both HA-Bis- GMA-g and HA-Bis-GMA-s were non-toxic to osteoblast cells and osteoblast cells were observed attached and attained morphology on the surface of composites as evidenced by SEM imaging [101]. In the extension work, they investigated the mechanical properties of high-density polyethylene (HDPE) structure fabricated using a 3D printing technique. In this investigation, two heat processes were followed in making 3D printed scaffolds, namely primary heating. It was observed that the heat treatment of HDPE scaffolds showed the highest tensile modulus and strength of about 0.7 GPa and 14.8 MPa compared to unsintered samples. The sintered scaffolds at 160 °C showed decreased porosity and increased tensile parameters compared to samples sintered at 180 °C for 15 min. While the thermogravimetric analysis results revealed that low weight residue produced by HDPE whereas large amount of residue produced by the 3D printed polyethylene sintered at 180 °C for 60 min. This indicates improved mechanical properties of sintered 3D printed constructs [101]. Leukers et al. fabricated hydroxyapatite (HA-S) granulate scaffolds using 3D printing followed by heat treatment. Approximately 82% cell viability was measured through tetrazolium assay (WST-1) which shows good seeding efficiency of HA’s scaffold w. Cells seeded on HA-S. However, cultured dynamically showed higher cell viability and proliferation over 7 days than statically cultured cells either on plastics or HA structures. Moreover, the HA-S scaffolds made by 3D printing showed no cytotoxicity after heat treatment [102]. In another study, Ge Gao et al. fabricated a new in vitro atherosclerosis model, which was comprised of a triple-layered artery equivalent (AE) with adjustable geometries and improved structural characteristics using a novel promising platform 3D in-bath coaxial cell printing method. It was observed that the novel AE constructed model has produced operational tissues that retorted to many stimulations presented inside the 3D printed scaffold due to the induction of endothelial dysfunction. Moreover, an occurrence of repeated hallmark events before atherosclerosis was notified in the presence of various vascular tissues under complicated and stenotic flows. However, the 3D printed construct model was further examined individually and combinedly to see the effect of cell co-culture and local disturbed flows as the initiation of regulating atherosclerosis and consequence of atorvastatin as dose dependent. The outcomes from the novel proposed research suggested that constructed AE model spotlighted the importance of 3D printing techniques and expanded the version of enhanced biomedical applications. It can create a big breakthrough in pathophysiology related to cardiovascular diseases (CVDs) and their associated drugs for effective treatments [72]. Although, 3D printing is a potential technique, which produces geometrically different porous structures in a 3D orientation and might effectively regulate the tissue microenvironment. Notably, by printing essential tissues, this technique increases physiological relevance and overcomes key constraints of traditional fabrication procedures, such as decreased repeatability, compatibility difficulties with porogens, and organic solvents. Indeed, using different polymers and efficiently controlling the microstructure of materials, this technology can quickly and accurately fabricate individualized or patient-specific tissue or organ models, avoiding the deformities of immune response and allograft rejection caused by traditional organ transplantation.

6.4 Heart valve

The use of hydrogel materials in tissue engineering heart valve techniques is being vastly investigated [103], [104], [105], [106]. In addition, hydrogels have recently been used to create starter scaffolds that are quickly remodeled by cells before being decellularized to form implantable valves, to imitate the native ECM environment and good grip cells inside electrospun engineered valves; and to integrate regional matrix or mechanical differences directly into engineered valves [107, 108]. Moreover, hydrogels are utilized to regulate and investigate mechanical and biochemical signals in the heart valve cell response [109], [110], [111]. As new material combinations are produced or materials are employed unprecedentedly, a key issue is to adjust hydrogel technology to optimal cell survival methods [107]. Automated 3D bioprinting of cells into the structure of the hydrogel valve allows controlled cell deposition inside the structure [103]. Although, a great degree of geometric control and shape closeness of a hydrogel implant scale may be obtained by employing photocrosslinks and 3D printed constructs [107]. Hence this part defines the direct and photocrosslinks 3D printed construct applications specifically used for a heart valve. Duan et al. fabricated living aortic valve conduits based on an alginate/gelatin hydrogel system via 3D printing. In this study, the cells investigated were aortic valve root cells (SMC) and leaflet cells (VIC) bioprinted within alginate/gelatin hydrogel scaffold using a dual syringe system. The MTT assay was performed on VIC and SMC encapsulated in alginate/gelatine hydrogel discs at both low (2 × 106 cells/mL) and high cell density (1 × 107 cells/mL). The tensile stress and modulus of SMC encapsulated constructs were found to be about 1.74 ± 0.29 MPa and 1.98 ± 0.15 MPa while hydrogels encapsulated with VIC showed reduced tensile strength and moduli compared to a cell free sample. The cell viability results showed that seeded SMC cells and VIC cells were viable over 7 days in culture and the viability of cells was 81.4 ± 3.4% for SMC and 83.2 ± 4% for VIC [112]. In their continuation, they developed 3D printed trileaflet valve constructs using hydrogels and human valve interstitial cells. In this work the hydrogels HA and gelatin were synthesized using metha acrylic anhydride to form Me-HA and Me-GA structures and 0.05% w/v 2-hydroxy-1(4-(hydroxyethoxy) phenyl)-2-methyl-1propanone was added to form gel precursors. Next, the cell-laden 3D printed constructs were fabricated by seeding human aortic valvular interstitial cells (HAVIC) in hydrogels at a density of 5 × 106 cells/mL and the viability of cells was determined using Live/Dead assay. The results showed that an increase in Me-Gel and Me-HA concentration resulted in lower stiffness and higher viscosity, facilitated cell spreading, and better maintained HAVIC fibroblast phenotype. It was found that the incorporated VIC in Me-HA/Me-Gel hydrogels were almost alive after 3-day and 7-day culture and showed the viability of >90% in all hydrogel conditions. Further, they also remodeled the matrix with enhanced collagen and high glycosaminoglycans for new tissue growth [113]. Hockaday et al. developed native anatomic and axis-symmetric aortic valve geometrical using 3D printing technology. In this study, they implemented a 3D printing strategy combining UV photo crosslinking with poly-ethylene glycol-diacrylate (PEG-DA) hydrogels to fabricate a complex and heterogeneous valve scaffold at different inner diameters of 12–22 mm. The printing system was performed using an extrusion-based 3D printing device. The cell viability was studied by seeding porcine aortic valve interstitial cells (PAVIC) into the PEG-DA scaffolds and culturing them for up to 21 days. The incorporated PEG-DA scaffolds showed a high elastic modulus of about 5.3 ± 0.9 to 74.9 ± 1.5 kPa compared to the control. The results showed that the 22 mm ID showed a larger printed shape fidelity as compared to the 12 mm ID where the shape fidelity was in the range respectively. Moreover, the PAVIC-incorporated scaffolds maintained viability of 100% over 21 days [114]. It can be concluded that photo crosslinking approach showed better results in terms of mechanical and cell viability in comparison with direct 3D printing of cells in hydrogels. However, UV light intensities and its exposure time is a big challenge while constructing 3D construct based on hydrogels. There is a need to explore more studies based on optimization of UV photo crosslinking-based 3D printing constructs.

6.5 Soft tissues

Appropriate material for soft tissue replacement can meet a wide range of therapeutic demands from cosmetic, reconstruction, and correctional reasons. It is reported that there is a rising demand for new procedures and materials that can improve soft tissue regeneration each year, with five million reconstruction surgeries [14, 115]. In this connection, Ting et al. reported the mechanical characterization of bioprinted 3D soft tissue constructs. In this study, the scaffold was prepared using gelatine/polysaccharide alginate hybrid materials as the matrix and C2C12 mouse myoblast cells were seeded into developed scaffolds at a density of 6 × 106 cells/mL. The cell viability was evaluated using a Live/Dead assay kit. The live/dead staining results showed that the average viability of cells was 54.72% within 2 h of printing. However, the value increased greatly after 24 h and very few dead cells were observed after two days. So, it was concluded that increasing porosity resulted was due to a decrease in strength of the construct. Moreover, the fabricated 3D printed constructs have shown a decreasing trend for both compressive modulus and strength during the first week, especially after 3 days of culture [116]. In extrusion-based 3D printing, the composite framework in the form of biomaterials was used for depositing the cell-laden hydrogels. In most articles, the biomaterials used were PCL, PLGA, and a combination of PLC/PLGA [117]. The use of biomaterials has been preferred for the fabrication of complex structures. Therefore, it would be a good choice to consider other biomaterials in developing a new complex structure. The cell-laden hydrogels 3D constructs supported by biomaterials also possess significant thermal stability and the enhanced cell viability of dispensed cells for new bone formation. Some articles have revealed that cell-laden hydrogels subjected to UV radiation resulted in enhanced cell viability and proliferation.

7 3D scaffolds prepared by laser-assisted 3D printing

3D bioprinting is a state-of-art in field of additive manufacturing that represents 3D printing along with biology. The process involved the deposition of biomaterials in a layer-by-layer manner on different sections when incorporated in biocompatible materials. Laser-assisted printing is used specifically for biological purposes where high resolution is required to print biomaterials [32]. Hence, this section of the review has explained examples related to 3D constructed scaffolds using laser-assisted 3D printing technique that includes maxillofacial and other related applications.

7.1 Maxillofacial

Bioprinting is an innovative technique in medical applications with strong potential. Amongst the existing bioprinting techniques LAB is a significant approach because of its excellent resolution, high cell viability, and capacity to deposit high-viscous bioink. The LAB technique can precisely regulate the cells to rebuild organ life [118]. It is a fact that serious facial asymmetry has a negative physical and spiritual impact on patients [119]. Therefore, this section described the maxillofacial application based on Laser-assisted 3D bioprinting. Michael et al. developed 3D skin constructs using 3D LAB. In this research NIH3T3 fibroblast and HaCaT keratinocytes were used for making skin constructs. The in vivo study was performed using dorsal skinfold chambers in the nude mice. The in vitro results showed that multilayered tissue was formed with collagen-producing fibroblasts but did not show any differentiation in keratinocytes (HaCaT) cells. The results showed that printed keratinocytes formed a multilayered epidermis with the start of differentiation and stratum corneum. Moreover, the proliferation of keratinocytes was found in suprabasal layers and the start of differentiation of keratinocytes in vivo was due to the presence of growth factors present in mice that were absent in vitro [120]. Bergmann et al. have designed customized implants for remodeling of maxillofacial and craniofacial defects in bone replacement. The customized implants were printed through a 3D printing technique consisting of β-TCP (40 wt%) and BGH glass (60 wt%). The experimental results revealed that the sintered 3D samples have shown four-point bending strength of about 14.9 MPa compared to unsintered samples. Furthermore, XRD analysis concluded that the sintered 3D samples exhibited a phase composition change to wollastonite (CaSiO3) and rhenanite (CaNaPO4) and both were biocompatible and biodegradable [121]. In another work, Klammert et al. prepared 3D implants using powdered calcium phosphate for the reconstruction of cranial and maxillofacial defects. In this work dilute phosphoric acid (H3PO4) was printed into tricalcium phosphate powder, resulting in the formation of dicalcium phosphate hydrate (brushite) while hydrothermal treatment of brushite implants led to the formation of dicalcium phosphate anhydrous (Monetite, CaHPO4). The developed 3D printed calcium phosphate implants showed an adequate accuracy of suitable biocompatibility and adjustable resorption behavior. They concluded that the mechanical properties of brushite and monetite matrices were less than that of titanium implants and would be suitable as placeholders for ingrowing bone tissue [122]. Using a 3DP technology and a precise selection of material during maxillofacial surgeries for complicated facial asymmetry might help to create newly developed 3D scaffolds with improved operation designs and more exact manipulation for tissue engineering applications.

7.2 Other 3D printing applications

LAB is an emergent tissue engineering tool that can recreate the anisotropy of live tissues by printing cells and fluid materials with a cell-level precision [123, 124]. Therefore, this part highlighted some other prominent applications of 3D printed constructs created by LAB. Catros et al. developed 2D and 3D tissue engineering constructs using LAB. In this work, they investigated the laser printing parameters for patterning and assembling nano-hydroxyapatite (nHA) and human osteoprogenitors with LAB. The cell-laden 3D printed construct was developed by seeding HOPs isolated from human bone marrow stromal cells (HBMSC) nHA bioink with a density of 30,000,000 cells/mL. The cell viability was characterized using Live/Dead Assay Kit. SEM, fluorescence microscopy and immunochemistry analysis showed that LAB did not alter the physicochemical properties of nHA nor the viability, proliferation, and phenotype of HOPs over time (up to 15 days) [125]. In their continuation, they developed 3D scaffolds using LAB. In this research, the PCL scaffolds were stacked using LBL techniques and seeding was on a single locus of the scaffolds. The prepared scaffolds were characterized using SEM, live/dead assay, and histology. The in vivo and in vitro studies were performed in NOD-SCID mice and the number of cells was quantified by a photon imager for 21 days in vitro and 2 months in vivo. The results showed that the LBL constructs had enhanced cell viability over 21 days. The integrity of printed papers was maintained by the use of PCL biopaper and the circular shape of MG63 cells was maintained after 4 days. Further, the LBL organization showed enhanced cell numbers favoring cell proliferation and tissue growth evident in histological sections [126]. Yu et al. designed a novel doughnut multi-layered drug delivery device (DDD) using the 3D technique. The new novel drug contained acetaminophen as a model drug, hydroxyl propyl methylcellulose as a matrix, and ethyl cellulose (EC) as a release-retardant material. It was revealed that fabricated multilayered DDDs using a 3D printing system showed strong adhesion between the barrier layer and the drug-contained region and offered linear profile for all different diameters, heights, concentrations of EC, and central hole diameters. The research paper also concluded that 3D printing had the potential to develop DDDs with complex design features which allows dosage adjustment of the DDD independently by changing the heights of the DDD [127].

Although Laser-assisted 3D printing has numerous advantages like good biocompatibility, high resolution, and great efficiency but the fabrication of 3D printed scaffolds by laser-assisted printing was not commonly useful due to some drawbacks. First of all, the use of many polymeric biomaterials in developing scaffolds was limited in laser-assisted printing where it requires additional chemical modifications to make the materials photopolymerizable. Since it has no nozzles (used in the inkjet and extrusion printers), it was difficult to deliver the material to the desired region for fabrication and the photopolymers filled the entire reservoir and had no intended space for polymerization, resulting in wastage of materials and increased costs. As discussed above, the use of laser-assisted 3D printing was found to be less useful and there is a need to utilize a combination of methods to overcome the drawbacks in the future.

8 Conclusions

Recently, 3D printing has been considered as the emerging tool that allows bioengineering researchers to fabricate complex 3D biological architectures with unprecedented capability. 3D printing has achieved many tissue engineering requirements that are needed for developing biofabrication systems. This review article discusses the various strategies of the 3D printing technique in developing scaffolds for tissue regeneration. Many research articles utilized CS (CaSiO3, calcium silicate) and β-TCP (tricalcium phosphate) for the preparation of 3D printed scaffolds for bone formation and found that sintered scaffolds showed no cytotoxicity and also enhanced mechanical properties of the biomaterials. The commonly used polymeric biomaterials for printing the 3D printed scaffolds were PCL and PLGA frameworks. However, it has been suggested that the 3D printed constructs were prepared using these biomaterials possess significant thermal stability and enhanced cell viability for new bone formation. In the future, we can modify some degradable polymeric biomaterials such as polyurethane, polylactic acid, polyanhydrides, polyglycolide, etc., for developing complex structures for tissue generation. Rather than developing a framework through fused deposition modeling, the scaffold preparation by electrospinning technique could be a promising approach in tissue regeneration. The fabricated cell-laden scaffolds subjected to photopolymerization revealed that the UV radiated 3D printed scaffolds have shown increased cell viability compared to bare scaffolds. In a few research papers, the fusion of bio-ink particles was performed before post-printing of the cell suspension into biopaper which developed tissue spheroids and produced smooth deposition of cellular aggregates and cell movement for tissue regeneration applications. The scaffolds prepared by both inkjet and extrusion-based 3D printing techniques showed significant impact on cell adherence, proliferation, and differentiation of new bone tissues evident by in vitro and in vivo studies. The 3D printed samples with growth factors have resulted in enhanced ECM, collagen content, and high GAG content for cell growth and new tissue formation. Due to some drawbacks in the preparation of 3D scaffolds for tissue regeneration, laser printing 3D technique, inkjet, and extrusion-based 3D printing were widely used. To overcome the drawbacks, the combination of bioprinters with different working principles could be a suitable solution. 3D printing requires a multidisciplinary team ranging from medical doctors, engineers, physicists, chemists, and lawyers working together to advance the current techniques. This in turn requires multibillion investments from the 3D printing companies and the public to develop small to large tissue-engineered organs successfully.


Corresponding author: Saravana Kumar Jaganathan, Department of Engineering, Faculty of Science and Engineering, University of Hull, Hull HU6 7RX, UK; Centre for Artificial Intelligence and Robotics, Universiti Teknologi Malaysia, Kuala Lumpur 54100, Malaysia; and School of Electrical Engineering, Faculty of Engineering, Universiti Teknologi Malaysia, Johor Bahru 81310, Malaysia, E-mail:

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work is not funded by any agency.

  3. Conflict of interest statement: The authors declare that they have no conflicts of interest regarding this article.

References

1. Fedorovich, N. E., Alblas, J., de Wijn, J. R., Hennink, W. E., Verbout, A. J., Dhert, W. J. A. Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng. 2007, 13, 1905–1925; https://doi.org/10.1089/ten.2006.0175.Search in Google Scholar

2. Poomathi, N., Singh, S., Prakash, C., Subramanian, A., Sahay, R., Cinappan, A., Ramakrishna, S. 3D printing in tissue engineering: a state of the art review of technologies and biomaterials. Rapid Prototyp. J. 2020, 26, 1313–1334; https://doi.org/10.1108/rpj-08-2018-0217.Search in Google Scholar

3. Lam, C. X. F., Mo, X. M., Teoh, S.-H., Hutmacher, D. W. Scaffold development using 3D printing with a starch-based polymer. Mater. Sci. Eng. C 2002, 20, 49–56; https://doi.org/10.1016/s0928-4931(02)00012-7.Search in Google Scholar

4. Prasopthum, A., Deng, Z., Khan, I. M., Yin, Z., Guo, B., Yang, J. Three dimensional printed degradable and conductive polymer scaffolds promote chondrogenic differentiation of chondroprogenitor cells. Biomater. Sci. 2020, 8, 4287–4298; https://doi.org/10.1039/d0bm00621a.Search in Google Scholar PubMed

5. Prasopthum, A., Cooper, M., Shakesheff, K. M., Yang, J. Three-dimensional printed scaffolds with controlled micro-/nanoporous surface topography direct chondrogenic and osteogenic differentiation of mesenchymal stem cells. ACS Appl. Mater. Interfaces 2019, 11, 18896–18906; https://doi.org/10.1021/acsami.9b01472.Search in Google Scholar PubMed

6. He, J., Xu, F., Dong, R., Guo, B., Li, D. Electrohydrodynamic 3D printing of microscale poly (ε-caprolactone) scaffolds with multi-walled carbon nanotubes. Biofabrication 2017, 9, 015007; https://doi.org/10.1088/1758-5090/aa53bc.Search in Google Scholar PubMed

7. Dong, R., Ma, P. X., Guo, B. Conductive biomaterials for muscle tissue engineering. Biomaterials 2020, 229, 119584; https://doi.org/10.1016/j.biomaterials.2019.119584.Search in Google Scholar PubMed

8. Hakkinen, K. M., Harunaga, J. S., Doyle, A. D., Yamada, K. M. Direct comparisons of the morphology, migration, cell adhesions, and actin cytoskeleton of fibroblasts in four different three-dimensional extracellular matrices. Tissue Eng. 2011, 17, 713–724.10.1089/ten.tea.2010.0273Search in Google Scholar PubMed PubMed Central

9. Qu, J., Zhao, X., Ma, P. X., Guo, B. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy. Acta Biomater. 2017, 58, 168–180; https://doi.org/10.1016/j.actbio.2017.06.001.Search in Google Scholar PubMed

10. Deng, Z., Hu, T., Lei, Q., He, J., Ma, P. X., Guo, B. Stimuli-responsive conductive nanocomposite hydrogels with high stretchability, self-healing, adhesiveness, and 3D printability for human motion sensing. ACS Appl. Mater. Interfaces 2019, 11, 6796–6808; https://doi.org/10.1021/acsami.8b20178.Search in Google Scholar PubMed

11. Rengier, F., Mehndiratta, A., von Tengg-Kobligk, H., Zechmann, C. M., Unterhinninghofen, R., Kauczor, H. U., Giesel, F. L. 3D printing based on imaging data: review of medical applications. Int. J. Comput. Assist. Radiol. Surg. 2010, 5, 335–341; https://doi.org/10.1007/s11548-010-0476-x.Search in Google Scholar

12. Marga, F., Jakab, K., Khatiwala, C., Shepherd, B., Dorfman, S., Hubbard, B., Colbert, S., Forgacs, G. Toward engineering functional organ modules by additive manufacturing. Biofabrication 2012, 4, 022001; https://doi.org/10.1088/1758-5082/4/2/022001.Search in Google Scholar

13. Chia, H. N., Wu, B. M. Recent advances in 3D printing of biomaterials. J. Biol. Eng. 2015, 9, 1–14; https://doi.org/10.1186/s13036-015-0001-4.Search in Google Scholar

14. Rodriguez, M. J., Brown, J., Giordano, J., Lin, S. J., Omenetto, F. G., Kaplan, D. L. Silk based bioinks for soft tissue reconstruction using 3-dimensional (3D) printing with in vitro and in vivo assessments. Biomaterials 2017, 117, 105–115; https://doi.org/10.1016/j.biomaterials.2016.11.046.Search in Google Scholar

15. Hutmacher, D. W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21, 2529–2543; https://doi.org/10.1016/s0142-9612(00)00121-6.Search in Google Scholar

16. Cheng, A., Schwartz, Z., Kahn, A., Li, X., Shao, Z., Sun, M., Ao, Y., Boyan, B. D., Chen, H. Advances in porous scaffold design for bone and cartilage tissue engineering and regeneration. Tissue Eng. B Rev. 2019, 25, 14–29; https://doi.org/10.1089/ten.teb.2018.0119.Search in Google Scholar PubMed PubMed Central

17. Hutmacher, D. W. Scaffold design and fabrication technologies for engineering tissues—state of the art and future perspectives. J. Biomater. Sci. Polym. Ed. 2001, 12, 107–124; https://doi.org/10.1163/156856201744489.Search in Google Scholar PubMed

18. Pati, F., Gantelius, J., Svahn, H. A. 3D bioprinting of tissue/organ models. Angew. Chem. Int. Ed. 2016, 55, 4650–4665; https://doi.org/10.1002/anie.201505062.Search in Google Scholar PubMed

19. Xu, T., Binder, K. W., Albanna, M. Z., Dice, D., Zhao, W., Yoo, J. J., Atala, A. Hybrid printing of mechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication 2012, 5, 015001; https://doi.org/10.1088/1758-5082/5/1/015001.Search in Google Scholar PubMed

20. Kačarević, Ž. P., Rider, P. M., Alkildani, S., Retnasingh, S., Smeets, R., Jung, O., Ivanišević, Z., Barbeck, M. An introduction to 3D bioprinting: possibilities, challenges and future aspects. Materials 2018, 11, 2199.10.3390/ma11112199Search in Google Scholar PubMed PubMed Central

21. Roth, E. A., Xu, T., Das, M., Gregory, C., Hickman, J. J., Boland, T. Inkjet printing for high-throughput cell patterning. Biomaterials 2004, 25, 3707–3715; https://doi.org/10.1016/j.biomaterials.2003.10.052.Search in Google Scholar PubMed

22. Cui, X., Breitenkamp, K., Lotz, M., D’Lima, D. Synergistic action of fibroblast growth factor‐2 and transforming growth factor‐beta1 enhances bioprinted human neocartilage formation. Biotechnol. Bioeng. 2012, 109, 2357–2368; https://doi.org/10.1002/bit.24488.Search in Google Scholar PubMed PubMed Central

23. Bishop, E. S., Mostafa, S., Pakvasa, M., Luu, H. H., Lee, M. J., Wolf, J. M., Ameer, G. A., He, T.-C., Reid, R. R. 3-D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends. Genes Dis. 2017, 4, 185–195; https://doi.org/10.1016/j.gendis.2017.10.002.Search in Google Scholar PubMed PubMed Central

24. Murphy, S. V., Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 2014, 32, 773–785; https://doi.org/10.1038/nbt.2958.Search in Google Scholar PubMed

25. Dwivedi, R., Mehrotra, D. 3D bioprinting and craniofacial regeneration. J. Oral Biol. Craniofac. Res. 2020, 10, 650–659; https://doi.org/10.1016/j.jobcr.2020.08.011.Search in Google Scholar PubMed PubMed Central

26. Algahtani, M. S., Mohammed, A. A., Ahmad, J. Extrusion-based 3D printing for pharmaceuticals: contemporary research and applications. Curr. Pharmaceut. Des. 2018, 24, 4991–5008; https://doi.org/10.2174/1381612825666190110155931.Search in Google Scholar PubMed

27. Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M., Sultana, T. Polymers for extrusion-based 3D printing of pharmaceuticals: a holistic materials–process perspective. Pharmaceutics 2020, 12, 124; https://doi.org/10.3390/pharmaceutics12020124.Search in Google Scholar PubMed PubMed Central

28. Valkenaers, H., Vogeler, F., Ferraris, E., Voet, A., Kruth, J.-P. A Novel Approach to Additive Manufacturing: Screw Extrusion 3D-Printing; Research Publishing: Singapore, 2013; pp. 235–238.10.3850/978-981-07-7247-5-359Search in Google Scholar

29. Daniyan, I. A., Balogun, V., Mpofu, K., Omigbodun, F. T. An interactive approach towards the development of an additive manufacturing technology for railcar manufacturing. Int. J. Interact. Des. Manuf. 2020, 14, 651–666; https://doi.org/10.1007/s12008-020-00659-8.Search in Google Scholar

30. Fielding, G. A., Bandyopadhyay, A., Bose, S. Effects of silica and zinc oxide doping on mechanical and biological properties of 3D printed tricalcium phosphate tissue engineering scaffolds. Dent. Mater. 2012, 28, 113–122; https://doi.org/10.1016/j.dental.2011.09.010.Search in Google Scholar PubMed PubMed Central

31. Xie, Z., Gao, M., Lobo, A. O., Webster, T. J. 3D bioprinting in tissue engineering for medical applications: the classic and the hybrid. Polymers 2020, 12, 1717; https://doi.org/10.3390/polym12081717.Search in Google Scholar PubMed PubMed Central

32. Vanaei, S., Parizi, M. S., Vanaei, S., Salemizadehparizi, F., Vanaei, H. R. An overview on materials and techniques in 3D bioprinting toward biomedical application. Eng. Regen. 2021, 2, 1–18; https://doi.org/10.1016/j.engreg.2020.12.001.Search in Google Scholar

33. Lin, Y. W., Tsou, K. L., Fay, C. D., Liu, X., Chung, J. H., Sharma, D., Jeiranikhameneh, A., Kuo, P. H., Tzeng, C. K., Wallace, G. G. A microvalve cell printing technique using riboflavin photosensitizer for selective cell patterning onto a retinal chip. Bioprinting 2020, 20, e00097; https://doi.org/10.1016/j.bprint.2020.e00097.Search in Google Scholar

34. Gao, G., Schilling, A. F., Yonezawa, T., Wang, J., Dai, G., Cui, X. Bioactive nanoparticles stimulate bone tissue formation in bioprinted three-dimensional scaffold and human mesenchymal stem cells. Biotechnol. J. 2014, 9, 1304–1311; https://doi.org/10.1002/biot.201400305.Search in Google Scholar PubMed

35. Saijo, H., Igawa, K., Kanno, Y., Mori, Y., Kondo, K., Shimizu, K., Suzuki, S., Chikazu, D., Iino, M., Anzai, M., Sasaki, N. Maxillofacial reconstruction using custom-made artificial bones fabricated by inkjet printing technology. J. Artif. Organs 2009, 12, 200–205; https://doi.org/10.1007/s10047-009-0462-7.Search in Google Scholar PubMed

36. Salah, M., Tayebi, L., Moharamzadeh, K., Naini, F. B. Three-dimensional bio-printing and bone tissue engineering: technical innovations and potential applications in maxillofacial reconstructive surgery. Maxillofac. Plast. Reconstr. Surg. 2020, 42, 1–9; https://doi.org/10.1186/s40902-020-00263-6.Search in Google Scholar PubMed PubMed Central

37. Inzana, J. A., Olvera, D., Fuller, S. M., Kelly, J. P., Graeve, O. A., Schwarz, E. M., Kates, S. L., Awad, H. A. 3D printing of composite calcium phosphate and collagen scaffolds for bone regeneration. Biomaterials 2014, 35, 4026–4034; https://doi.org/10.1016/j.biomaterials.2014.01.064.Search in Google Scholar PubMed PubMed Central

38. Cooper, G. M., Miller, E. D., Decesare, G. E., Usas, A., Lensie, E. L., Bykowski, M. R., Huard, J., Weiss, L. E., Losee, J. E., Campbell, P. G. Inkjet-based biopatterning of bone morphogenetic protein-2 to spatially control calvarial bone formation. Tissue Eng. 2010, 16, 1749–1759; https://doi.org/10.1089/ten.tea.2009.0650.Search in Google Scholar

39. Fielding, G., Bose, S. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo. Acta Biomater. 2013, 9, 9137–9148; https://doi.org/10.1016/j.actbio.2013.07.009.Search in Google Scholar PubMed PubMed Central

40. Wu, C., Fan, W., Zhou, Y., Luo, Y., Gelinsky, M., Chang, J., Xiao, Y. 3D-printing of highly uniform CaSiO3 ceramic scaffolds: preparation, characterization and in vivo osteogenesis. J. Mater. Chem. 2012, 22, 12288–12295; https://doi.org/10.1039/c2jm30566f.Search in Google Scholar

41. Gao, G. F., Schilling, A. F., Hubbell, K., Yonezawa, T., Truong, D., Hong, Y., Dai, G. H., Cui, X. F. Improved properties of bone and cartilage tissue from 3D inkjet-bioprinted human mesenchymal stem cells by simultaneous deposition and photocrosslinking in PEG-GelMA. Biotechnol. Lett. 2015, 37, 2349–2355; https://doi.org/10.1007/s10529-015-1921-2.Search in Google Scholar PubMed

42. Cui, X., Boland, T., DD’Lima, D., K Lotz, M. Thermal inkjet printing in tissue engineering and regenerative medicine. Recent Pat. Drug Deliv. Formulation 2012, 6, 149–155; https://doi.org/10.2174/187221112800672949.Search in Google Scholar PubMed PubMed Central

43. Rouwkema, J., Rivron, N. C., van Blitterswijk, C. A. Vascularization in tissue engineering. Trends Biotechnol. 2008, 26, 434–441; https://doi.org/10.1016/j.tibtech.2008.04.009.Search in Google Scholar PubMed

44. Dobos, A., Gantner, F., Markovic, M., Van Hoorick, J., Tytgat, L., Van Vlierberghe, S., Ovsianikov, A. On-chip high-definition bioprinting of microvascular structures. Biofabrication 2020, 13, 015016; https://doi.org/10.1088/1758-5090/abb063.Search in Google Scholar PubMed

45. Kim, J. J., Hou, L., Huang, N. F. Vascularization of three-dimensional engineered tissues for regenerative medicine applications. Acta Biomater. 2016, 41, 17–26; https://doi.org/10.1016/j.actbio.2016.06.001.Search in Google Scholar PubMed PubMed Central

46. Burton, A. C. Relation of structure to function of the tissues of the wall of blood vessels. Physiol. Rev. 1954, 34, 619–642; https://doi.org/10.1152/physrev.1954.34.4.619.Search in Google Scholar PubMed

47. Yan, L. W., Liu, S. L., Qi, J., Zhang, Z. P., Zhong, J. X., Li, Q., Liu, X. L., Zhu, Q. T., Yao, Z., Lu, Y., Gu, L. Three-dimensional reconstruction of internal fascicles and microvascular structures of human peripheral nerves. Int. J. Numer. Methods Biomed. Eng. 2019, 35; https://doi.org/10.1002/cnm.3245.Search in Google Scholar PubMed

48. Nakamura, M., Kobayashi, A., Takagi, F., Watanabe, A., Hiruma, Y., Ohuchi, K., Iwasaki, Y., Horie, M., Morita, I., Takatani, S. Biocompatible inkjet printing technique for designed seeding of individual living cells. Tissue Eng. 2005, 11, 1658–1666; https://doi.org/10.1089/ten.2005.11.1658.Search in Google Scholar PubMed

49. Cui, X., Breitenkamp, K., Finn, M. G., Lotz, M., D’Lima, D. D. Direct human cartilage repair using three-dimensional bioprinting technology. Tissue Eng. 2012, 18, 1304–1312; https://doi.org/10.1089/ten.TEA.2011.0543.Search in Google Scholar PubMed PubMed Central

50. Moon, S., Hasan, S. K., Song, Y. S., Xu, F., Keles, H. O., Manzur, F., Mikkilineni, S., Hong, J. W., Nagatomi, J., Haeggstrom, E., Khademhosseini, A. Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng. C Methods 2009, 16, 157–166; https://doi.org/10.1089/ten.TEC.2009.0179.Search in Google Scholar PubMed PubMed Central

51. Jeon, O., Lee, K., Alsberg, E. Spatial micropatterning of growth factors in 3D hydrogels for location-specific regulation of cellular behaviors. Small 2018, 14; https://doi.org/10.1002/smll.201800579.Search in Google Scholar PubMed PubMed Central

52. Moon, S., Hasan, S. K., Song, Y. S., Xu, F., Keles, H. O., Manzur, F., Mikkilineni, S., Hong, J. W., Nagatomi, J., Haeggstrom, E. Layer by layer three-dimensional tissue epitaxy by cell-laden hydrogel droplets. Tissue Eng. C Methods 2010, 16, 157–166; https://doi.org/10.1089/ten.tec.2009.0179.Search in Google Scholar PubMed PubMed Central

53. Lee, Y. B., Polio, S., Lee, W., Dai, G., Menon, L., Carroll, R. S., Yoo, S. S. Bio-printing of collagen and VEGF-releasing fibrin gel scaffolds for neural stem cell culture. Exp. Neurol. 2010, 223, 645–652; https://doi.org/10.1016/j.expneurol.2010.02.014.Search in Google Scholar PubMed

54. Phillippi, J. A., Miller, E., Weiss, L., Huard, J., Waggoner, A., Campbell, P. Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle‐and bone‐like subpopulations. Stem Cell. 2008, 26, 127–134; https://doi.org/10.1634/stemcells.2007-0520.Search in Google Scholar PubMed

55. Yerneni, S. S., Whiteside, T. L., Weiss, L. E., Campbell, P. G. Bioprinting exosome-like extracellular vesicle microenvironments. Bioprinting 2019, 13, e00041; https://doi.org/10.1016/j.bprint.2019.e00041.Search in Google Scholar

56. Ferris, C. J., Gilmore, K. J., Beirne, S., McCallum, D., Wallace, G. G. Bio-ink for on-demand printing of living cells. Biomater. Sci. 2013, 1, 224–230; https://doi.org/10.1039/c2bm00114d.Search in Google Scholar PubMed

57. Cui, X., Dean, D., Ruggeri, Z. M., Boland, T. Cell damage evaluation of thermal inkjet printed Chinese hamster ovary cells. Biotechnol. Bioeng. 2010, 106, 963–969; https://doi.org/10.1002/bit.22762.Search in Google Scholar PubMed

58. Solis, L. H., Ayala, Y., Portillo, S., Varela-Ramirez, A., Aguilera, R., Boland, T. Thermal inkjet bioprinting triggers the activation of the VEGF pathway in human microvascular endothelial cells in vitro. Biofabrication 2019, 11, 045005; https://doi.org/10.1088/1758-5090/ab25f9.Search in Google Scholar PubMed PubMed Central

59. Zhao, Y., Li, Y., Mao, S., Sun, W., Yao, R. The influence of printing parameters on cell survival rate and printability in microextrusion-based 3D cell printing technology. Biofabrication 2015, 7, 045002; https://doi.org/10.1088/1758-5090/7/4/045002.Search in Google Scholar PubMed

60. Xu, T., Jin, J., Gregory, C., Hickman, J. J., Boland, T. Inkjet printing of viable mammalian cells. Biomaterials 2005, 26, 93–99; https://doi.org/10.1016/j.biomaterials.2004.04.011.Search in Google Scholar PubMed

61. Barui, S., Saunders, R. E., Naskar, S., Basu, B., Derby, B. Acoustic poration and dynamic healing of mammalian cell membranes during inkjet printing. ACS Biomater. Sci. Eng. 2019, 6, 749–757; https://doi.org/10.1021/acsbiomaterials.9b01635.Search in Google Scholar PubMed

62. Atala, A. Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res. 2004, 7, 15–31; https://doi.org/10.1089/154916804323105053.Search in Google Scholar PubMed

63. Xu, T., Zhao, W., Zhu, J.-M., Albanna, M. Z., Yoo, J. J., Atala, A. Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology. Biomaterials 2013, 34, 130–139; https://doi.org/10.1016/j.biomaterials.2012.09.035.Search in Google Scholar PubMed

64. Wang, X. Intelligent freeform manufacturing of complex organs. Artif. Organs 2012, 36, 951–961; https://doi.org/10.1111/j.1525-1594.2012.01499.x.Search in Google Scholar PubMed

65. Liu, F., Wang, X. H. Synthetic polymers for organ 3D printing. Polymers 2020, 12; https://doi.org/10.3390/polym12081765.Search in Google Scholar PubMed PubMed Central

66. Abdulghani, S., Morouço, P. G. Biofabrication for osteochondral tissue regeneration: bioink printability requirements. J. Mater. Sci. Mater. Med. 2019, 30, 20; https://doi.org/10.1007/s10856-019-6218-x.Search in Google Scholar PubMed

67. Hajdu, Z., Mironov, V., Mehesz, A. N., Norris, R. A., Markwald, R. R., Visconti, R. P. Tissue spheroid fusion‐based in vitro screening assays for analysis of tissue maturation. J. Tissue Eng. Regen. Med. 2010, 4, 659–664; https://doi.org/10.1002/term.291.Search in Google Scholar PubMed PubMed Central

68. Hakam, M. S., Imani, R., Abolfathi, N., Fakhrzadeh, H., Sharifi, A. M. Evaluation of fibrin-gelatin hydrogel as biopaper for application in skin bioprinting: an in-vitro study. Biomed. Mater. Eng. 2016, 27, 669–682; https://doi.org/10.3233/BME-161617.Search in Google Scholar PubMed

69. Lee, W., Bae, C. Y., Kwon, S., Son, J., Kim, J., Jeong, Y., Yoo, S. S., Park, J. K. Cellular hydrogel biopaper for patterned 3D cell culture and modular tissue reconstruction. Adv. Healthc. Mater. 2012, 1, 635–639; https://doi.org/10.1002/adhm.201200158.Search in Google Scholar PubMed

70. Jakab, K., Norotte, C., Marga, F., Murphy, K., Vunjak-Novakovic, G., Forgacs, G. Tissue engineering by self-assembly and bio-printing of living cells. Biofabrication 2010, 2, 022001; https://doi.org/10.1088/1758-5082/2/2/022001.Search in Google Scholar PubMed PubMed Central

71. Rider, P., Kačarević, Ž. P., Alkildani, S., Retnasingh, S., Barbeck, M. Bioprinting of tissue engineering scaffolds. J. Tissue Eng. 2018, 9, 2041731418802090.10.1177/2041731418802090Search in Google Scholar PubMed PubMed Central

72. Gao, G., Park, W., Kim, B. S., Ahn, M., Chae, S., Cho, W.-W., Kim, J., Lee, J. Y., Jang, J., Cho, D.-W. Construction of a novel in vitro atherosclerotic model from geometry-tunable artery equivalents engineered via in-bath coaxial cell printing. Adv. Funct. Mater. 2021, 31, 2008878; https://doi.org/10.1002/adfm.202008878.Search in Google Scholar

73. Biscaia, S., Dabrowska, E., Tojeira, A., Horta, J., Carreira, P., Morouco, P., Mateus, A., Alves, N., Mitchell, G., Alves, N. Development of heterogeneous structures with polycaprolactone-alginate using a new 3D printing system - BioMED(beta eta): design and processing. In International Conference on Sustainable and Intelligent Manufacturing (RESIM 2016); Mateus, A., Ed. Elsevier: Amsterdam, Netherland, 12, 2017; pp. 113–119.10.1016/j.promfg.2017.08.015Search in Google Scholar

74. Pati, F., Shim, J.-H., Lee, J.-S., Cho, D.-W. 3D printing of cell-laden constructs for heterogeneous tissue regeneration. Manuf. Lett. 2013, 1, 49–53; https://doi.org/10.1016/j.mfglet.2013.09.004.Search in Google Scholar

75. Lee, J.-S., Hong, J. M., Jung, J. W., Shim, J.-H., Oh, J.-H., Cho, D.-W. 3D printing of composite tissue with complex shape applied to ear regeneration. Biofabrication 2014, 6, 024103; https://doi.org/10.1088/1758-5082/6/2/024103.Search in Google Scholar PubMed

76. Zhang, J. T., Zhang, S. S., Liu, C. G., Kankala, R. K., Chen, A. Z., Wang, S. B. Low-temperature extrusion-based 3D printing of icariin-laden scaffolds for osteogenesis enrichment. Regen. Ther. 2021, 16, 53–62; https://doi.org/10.1016/j.reth.2021.01.001.Search in Google Scholar PubMed PubMed Central

77. Pati, F., Song, T.-H., Rijal, G., Jang, J., Kim, S. W., Cho, D.-W. Ornamenting 3D printed scaffolds with cell-laid extracellular matrix for bone tissue regeneration. Biomaterials 2015, 37, 230–241; https://doi.org/10.1016/j.biomaterials.2014.10.012.Search in Google Scholar PubMed

78. Narayanan, L. K., Kumar, A., Tan, Z. G., Bernacki, S., Starly, B., Shirwaiker, R. A. Alginate microspheroid encapsulation and delivery of MG-63 cells into polycaprolactone scaffolds: a new biofabrication approach for tissue engineering constructs. J. Nanotechnol. Eng. Med. 2015, 6, 1–8; https://doi.org/10.1115/1.4031174.Search in Google Scholar

79. Shim, J.-H., Yoon, M.-C., Jeong, C.-M., Jang, J., Jeong, S.-I., Cho, D.-W., Huh, J.-B. Efficacy of rhBMP-2 loaded PCL/PLGA/β-TCP guided bone regeneration membrane fabricated by 3D printing technology for reconstruction of calvaria defects in rabbit. Biomed. Mater. 2014, 9, 065006; https://doi.org/10.1088/1748-6041/9/6/065006.Search in Google Scholar PubMed

80. Holmes, B., Bulusu, K., Plesniak, M., Zhang, L. G. A synergistic approach to the design, fabrication and evaluation of 3D printed micro and nano featured scaffolds for vascularized bone tissue repair. Nanotechnology 2016, 27, 064001; https://doi.org/10.1088/0957-4484/27/6/064001.Search in Google Scholar PubMed PubMed Central

81. Fedorovich, N. E., Schuurman, W., Wijnberg, H. M., Prins, H.-J., Van Weeren, P. R., Malda, J., Alblas, J., Dhert, W. J. A. Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng. C Methods 2012, 18, 33–44; https://doi.org/10.1089/ten.tec.2011.0060.Search in Google Scholar

82. Tarafder, S., Davies, N. M., Bandyopadhyay, A., Bose, S. 3D printed tricalcium phosphate bone tissue engineering scaffolds: effect of SrO and MgO doping on in vivo osteogenesis in a rat distal femoral defect model. Biomater. Sci. 2013, 1, 1250–1259; https://doi.org/10.1039/c3bm60132c.Search in Google Scholar PubMed PubMed Central

83. Tarafder, S., Balla, V. K., Davies, N. M., Bandyopadhyay, A., Bose, S. Microwave‐sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering. J. Tissue Eng. Regen. Med. 2013, 7, 631–641; https://doi.org/10.1002/term.555.Search in Google Scholar PubMed PubMed Central

84. Santos, C. F., Silva, A. P., Lopes, L., Pires, I., Correia, I. J. Design and production of sintered β-tricalcium phosphate 3D scaffolds for bone tissue regeneration. Mater. Sci. Eng. C 2012, 32, 1293–1298; https://doi.org/10.1016/j.msec.2012.04.010.Search in Google Scholar

85. Kundu, J., Shim, J. H., Jang, J., Kim, S. W., Cho, D. W. An additive manufacturing‐based PCL–alginate–chondrocyte bioprinted scaffold for cartilage tissue engineering. J. Tissue Eng. Regen. Med. 2015, 9, 1286–1297; https://doi.org/10.1002/term.1682.Search in Google Scholar PubMed

86. Shao, H., Yang, X., He, Y., Fu, J., Liu, L., Ma, L., Zhang, L., Yang, G., Gao, C., Gou, Z. Bioactive glass-reinforced bioceramic ink writing scaffolds: sintering, microstructure and mechanical behavior. Biofabrication 2015, 7, 035010; https://doi.org/10.1088/1758-5090/7/3/035010.Search in Google Scholar PubMed

87. Da Silva Morais, A., Vieira, S., Zhao, X., Mao, Z., Gao, C., Oliveira, J. M., Reis, R. L. Advanced biomaterials and processing methods for liver regeneration: state‐of‐the‐art and future trends. Adv. Healthc. Mater. 2020, 9, 1901435; https://doi.org/10.1002/adhm.201901435.Search in Google Scholar PubMed

88. Chae, S., Lee, S.-S., Choi, Y.-J., Hong, D. H., Gao, G., Wang, J. H., Cho, D.-W. 3D cell-printing of biocompatible and functional meniscus constructs using meniscus‐derived bioink. Biomaterials 2021, 267, 120466; https://doi.org/10.1016/j.biomaterials.2020.120466.Search in Google Scholar PubMed

89. Chae, S., Sun, Y., Choi, Y. J., Ha, D. H., Jeon, I. H., Cho, D. W. 3D cell-printing of tendon-bone interface using tissue-derived extracellular matrix bioinks for chronic rotator cuff repair. Biofabrication 2020, 13; https://doi.org/10.1088/1758-5090/abd159.Search in Google Scholar PubMed

90. Naskar, D., Ghosh, A. K., Mandal, M., Das, P., Nandi, S. K., Kundu, S. C. Dual growth factor loaded nonmulberry silk fibroin/carbon nanofiber composite 3D scaffolds for in vitro and in vivo bone regeneration. Biomaterials 2017, 136, 67–85; https://doi.org/10.1016/j.biomaterials.2017.05.014.Search in Google Scholar PubMed

91. Kankala, R. K., Zhu, K., Sun, X.-N., Liu, C.-G., Wang, S.-B., Chen, A.-Z. Cardiac tissue engineering on the nanoscale. ACS Biomater. Sci. Eng. 2018, 4, 800–818; https://doi.org/10.1021/acsbiomaterials.7b00913.Search in Google Scholar PubMed

92. Shim, J.-H., Kim, J. Y., Park, M., Park, J., Cho, D.-W. Development of a hybrid scaffold with synthetic biomaterials and hydrogel using solid freeform fabrication technology. Biofabrication 2011, 3, 034102; https://doi.org/10.1088/1758-5082/3/3/034102.Search in Google Scholar PubMed

93. Domingos, M., Intranuovo, F., Russo, T., De Santis, R., Gloria, A., Ambrosio, L., Ciurana, J., Bartolo, P. The first systematic analysis of 3D rapid prototyped poly (ε-caprolactone) scaffolds manufactured through BioCell printing: the effect of pore size and geometry on compressive mechanical behaviour and in vitro hMSC viability. Biofabrication 2013, 5, 045004; https://doi.org/10.1088/1758-5082/5/4/045004.Search in Google Scholar PubMed

94. Seyednejad, H., Gawlitta, D., Kuiper, R. V., de Bruin, A., van Nostrum, C. F., Vermonden, T., Dhert, W. J., Hennink, W. E. In vivo biocompatibility and biodegradation of 3D-printed porous scaffolds based on a hydroxyl-functionalized poly (ε-caprolactone). Biomaterials 2012, 33, 4309–4318; https://doi.org/10.1016/j.biomaterials.2012.03.002.Search in Google Scholar PubMed

95. Billiet, T., Gevaert, E., De Schryver, T., Cornelissen, M., Dubruel, P. The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability. Biomaterials 2014, 35, 49–62; https://doi.org/10.1016/j.biomaterials.2013.09.078.Search in Google Scholar PubMed

96. Rajaram, A., Schreyer, D. J., Chen, D. X. B. Use of the polycation polyethyleneimine to improve the physical properties of alginate–hyaluronic acid hydrogel during fabrication of tissue repair scaffolds. J. Biomater. Sci. Polym. Ed. 2015, 26, 433–445; https://doi.org/10.1080/09205063.2015.1016383.Search in Google Scholar PubMed

97. Skardal, A., Zhang, J., McCoard, L., Xu, X., Oottamasathien, S., Prestwich, G. D. Photocrosslinkable hyaluronan-gelatin hydrogels for two-step bioprinting. Tissue Eng. 2010, 16, 2675–2685; https://doi.org/10.1089/ten.tea.2009.0798.Search in Google Scholar PubMed PubMed Central

98. Zhang, J., Zhao, S., Zhu, Y., Huang, Y., Zhu, M., Tao, C., Zhang, C. Three-dimensional printing of strontium-containing mesoporous bioactive glass scaffolds for bone regeneration. Acta Biomater. 2014, 10, 2269–2281; https://doi.org/10.1016/j.actbio.2014.01.001.Search in Google Scholar PubMed

99. Huang, W., Zheng, Q., Sun, W., Xu, H., Yang, X. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int. J. Pharm. 2007, 339, 33–38; https://doi.org/10.1016/j.ijpharm.2007.02.021.Search in Google Scholar PubMed

100. Chung, J. H., Naficy, S., Yue, Z., Kapsa, R., Quigley, A., Moulton, S. E., Wallace, G. G. Bio-ink properties and printability for extrusion printing living cells. Biomater. Sci. 2013, 1, 763–773; https://doi.org/10.1039/c3bm00012e.Search in Google Scholar PubMed

101. Suwanprateeb, J., Kerdsook, S., Boonsiri, T., Pratumpong, P. Evaluation of heat treatment regimes and their influences on the properties of powder‐printed high‐density polyethylene bone implant. Polym. Int. 2011, 60, 758–764; https://doi.org/10.1002/pi.3006.Search in Google Scholar

102. Leukers, B., Gülkan, H., Irsen, S. H., Milz, S., Tille, C., Seitz, H., Schieker, M. Biocompatibility of ceramic scaffolds for bone replacement made by 3D printing. Mat.-wiss. u. Werkstofftech. 2005, 36, 781–787; https://doi.org/10.1002/mawe.200500968.Search in Google Scholar

103. Duan, B., Hockaday, L. A., Kang, K. H., Butcher, J. T. 3D bioprinting of heterogeneous aortic valve conduits with alginate/gelatin hydrogels. J. Biomed. Mater. Res. 2013, 101, 1255–1264; https://doi.org/10.1002/jbm.a.34420.Search in Google Scholar PubMed PubMed Central

104. Zhu, J. Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering. Biomaterials 2010, 31, 4639–4656; https://doi.org/10.1016/j.biomaterials.2010.02.044.Search in Google Scholar PubMed PubMed Central

105. Tseng, H., Puperi, D. S., Kim, E. J., Ayoub, S., Shah, J. V., Cuchiara, M. L., West, J. L., Grande-Allen, K. J. Anisotropic poly (ethylene glycol)/polycaprolactone hydrogel–fiber composites for heart valve tissue engineering. Tissue Eng. 2014, 20, 2634–2645; https://doi.org/10.1089/ten.TEA.2013.0397.Search in Google Scholar PubMed PubMed Central

106. Tseng, H., Cuchiara, M. L., Durst, C. A., Cuchiara, M. P., Lin, C. J., West, J. L., Grande-Allen, K. J. Fabrication and mechanical evaluation of anatomically-inspired quasilaminate hydrogel structures with layer-specific formulations. Ann. Biomed. Eng. 2013, 41, 398–407; https://doi.org/10.1007/s10439-012-0666-5.Search in Google Scholar PubMed PubMed Central

107. Kang, L. H., Armstrong, P. A., Lee, L. J., Duan, B., Kang, K. H., Butcher, J. T. Optimizing photo-encapsulation viability of heart valve cell types in 3D printable composite hydrogels. Ann. Biomed. Eng. 2017, 45, 360–377; https://doi.org/10.1007/s10439-016-1619-1.Search in Google Scholar PubMed PubMed Central

108. Guo, Z., Xia, J., Mi, S., Sun, W. Mussel-inspired naturally derived double-network hydrogels and their application in 3D printing: from soft, injectable bioadhesives to mechanically strong hydrogels. ACS Biomater. Sci. Eng. 2020, 6, 1798–1808; https://doi.org/10.1021/acsbiomaterials.9b01864.Search in Google Scholar PubMed

109. Durst, C. A., Cuchiara, M. P., Mansfield, E. G., West, J. L., Grande-Allen, K. J. Flexural characterization of cell encapsulated PEGDA hydrogels with applications for tissue engineered heart valves. Acta Biomater. 2011, 7, 2467–2476; https://doi.org/10.1016/j.actbio.2011.02.018.Search in Google Scholar PubMed PubMed Central

110. Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., Xu, F. Functional and biomimetic materials for engineering of the three-dimensional cell microenvironment. Chem. Rev. 2017, 117, 12764–12850; https://doi.org/10.1021/acs.chemrev.7b00094.Search in Google Scholar PubMed PubMed Central

111. Kloxin, A. M., Benton, J. A., Anseth, K. S. In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 2010, 31, 1–8; https://doi.org/10.1016/j.biomaterials.2009.09.025.Search in Google Scholar PubMed PubMed Central

112. Duan, B., Xu, C., Das, S., Chen, J. M., Butcher, J. T. Spatial regulation of valve interstitial cell phenotypes within three-dimensional micropatterned hydrogels. ACS Biomater. Sci. Eng. 2019, 5, 1416–1425; https://doi.org/10.1021/acsbiomaterials.8b01280.Search in Google Scholar PubMed

113. Duan, B., Kapetanovic, E., Hockaday, L. A., Butcher, J. T. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta Biomater. 2014, 10, 1836–1846; https://doi.org/10.1016/j.actbio.2013.12.005.Search in Google Scholar PubMed PubMed Central

114. Hockaday, L., Kang, K., Colangelo, N., Cheung, P., Duan, B., Malone, E., Wu, J., Girardi, L., Bonassar, L., Lipson, H. Rapid 3D printing of anatomically accurate and mechanically heterogeneous aortic valve hydrogel scaffolds. Biofabrication 2012, 4, 035005; https://doi.org/10.1088/1758-5082/4/3/035005.Search in Google Scholar PubMed PubMed Central

115. Jorgensen, A. M., Varkey, M., Gorkun, A., Clouse, C., Xu, L., Chou, Z. S., Murphy, S. V., Molnar, J., Lee, S. J., Yoo, J. J., Soker, S., Atala, A. Bioprinted skin recapitulates normal collagen remodeling in full-thickness wounds. Tissue Eng. 2020, 26, 512–526; https://doi.org/10.1089/ten.TEA.2019.0319.Search in Google Scholar PubMed PubMed Central

116. Zhang, T., Yan, K. C., Ouyang, L., Sun, W. Mechanical characterization of bioprinted in vitro soft tissue models. Biofabrication 2013, 5, 045010; https://doi.org/10.1088/1758-5082/5/4/045010.Search in Google Scholar PubMed

117. Nikolova, M. P., Chavali, M. S. Recent advances in biomaterials for 3D scaffolds: a review. Bioact. Mater. 2019, 4, 271–292; https://doi.org/10.1016/j.bioactmat.2019.10.005.Search in Google Scholar PubMed PubMed Central

118. Dou, C., Perez, V., Qu, J., Tsin, A., Xu, B., Li, J. A state-of-the-art review of laser-assisted bioprinting and its future research trends. ChemBioEng Rev. 2021, 8, 517–534.10.1002/cben.202000037Search in Google Scholar

119. Wang, L., Tian, D., Sun, X. M., Xiao, Y. J., Chen, L., Wu, G. M. The precise repositioning instrument for genioplasty and a three-dimensional printing technique for treatment of complex facial asymmetry. Aesthetic Plast. Surg. 2017, 41, 919–929; https://doi.org/10.1007/s00266-017-0875-2.Search in Google Scholar PubMed

120. Michael, S., Sorg, H., Peck, C.-T., Koch, L., Deiwick, A., Chichkov, B., Vogt, P. M., Reimers, K. Tissue engineered skin substitutes created by laser-assisted bioprinting form skin-like structures in the dorsal skin fold chamber in mice. PLoS One 2013, 8, e57741; https://doi.org/10.1371/journal.pone.0057741.Search in Google Scholar PubMed PubMed Central

121. Bergmann, C., Lindner, M., Zhang, W., Koczur, K., Kirsten, A., Telle, R., Fischer, H. 3D printing of bone substitute implants using calcium phosphate and bioactive glasses. J. Eur. Ceram. Soc. 2010, 30, 2563–2567; https://doi.org/10.1016/j.jeurceramsoc.2010.04.037.Search in Google Scholar

122. Klammert, U., Gbureck, U., Vorndran, E., Rödiger, J., Meyer-Marcotty, P., Kübler, A. C. 3D powder printed calcium phosphate implants for reconstruction of cranial and maxillofacial defects. J. Cranio-Maxillofacial Surg. 2010, 38, 565–570; https://doi.org/10.1016/j.jcms.2010.01.009.Search in Google Scholar PubMed

123. Guillotin, B., Catros, S., Keriquel, V., Souquet, A., Fontaine, A., Remy, M., Fricain, J. C., Guillemot, F. 5 - rapid prototyping of complex tissues with laser assisted bioprinting (LAB). In Rapid Prototyping of Biomaterials; Narayan, R., Ed.; Woodhead Publishing: Cambridge, 2014; pp. 156–175.10.1533/9780857097217.156Search in Google Scholar

124. Yu, J., Park, S. A., Kim, W. D., Ha, T., Xin, Y.-Z., Lee, J., Lee, D. Current advances in 3D bioprinting technology and its applications for tissue engineering. Polymers 2020, 12; https://doi.org/10.3390/polym12122958.Search in Google Scholar PubMed PubMed Central

125. Guillotin, B., Catros, S., Keriquel, V., Souquet, A., Fontaine, A., Remy, M., Fricain, J.-C., Guillemot, F. Rapid prototyping of complex tissues with laser-assisted bioprinting (LAB). In Rapid Prototyping of Biomaterials; Woodhead Publishing: Cambridge, 2014; pp. 165–182.10.1016/B978-0-08-102663-2.00007-1Search in Google Scholar

126. Kérourédan, O., Bourget, J.-M., Rémy, M., Crauste-Manciet, S., Kalisky, J., Catros, S., Thébaud, N. B., Devillard, R. Micropatterning of endothelial cells to create a capillary-like network with defined architecture by laser-assisted bioprinting. J. Mater. Sci. Mater. Med. 2019, 30, 28.10.1007/s10856-019-6230-1Search in Google Scholar PubMed

127. Yu, D.-G., Branford-White, C., Ma, Z.-H., Zhu, L.-M., Li, X.-Y., Yang, X.-L. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int. J. Pharm. 2009, 370, 160–166; https://doi.org/10.1016/j.ijpharm.2008.12.008.Search in Google Scholar PubMed

Received: 2021-02-20
Accepted: 2021-12-01
Published Online: 2022-01-10
Published in Print: 2022-03-28

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 6.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/polyeng-2021-0059/html
Scroll to top button